Report for Combined Biotech 13F Filings for quarter ending on 2025-06-30 (Compiled by @StuckInStock) (Adar1, Avoro, Baker Brothers, BVF, Casdin, Cormorant, Deep Track, EcoR1, Logos, Opaleye, Orbimed, Perceptive, RA Capital, Tang)
Top 40 Stock Holdings by Value
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | ASND | 2025-06-30 | Ascendis Pharma A/S | 165.05 | 9,923,581,952.00 | 25.93% | 59,372,631.00 | 2015-01-28 | 2806680359 | 16261184 | 5 | adar1-avoro-perceptive-racapital-orbimed |
| 1 | INCY | 2025-06-30 | Incyte Corporation | 58.21 | 11,265,032,192.00 | -20.77% | 161,370,279.00 | 1993-11-04 | 2093617028 | 30743275 | 1 | baker |
| 2 | MLTX | 2025-06-30 | MoonLake Immunotherapeutics | 34.90 | 2,208,566,272.00 | -22.88% | 28,073,483.00 | 2020-10-20 | 1540124153 | 32629749 | 5 | adar1-avoro-bvf-cormorant-logos |
| 3 | MDGL | 2025-06-30 | Madrigal Pharmaceuticals, Inc. | 301.66 | 6,660,712,960.00 | -1.77% | 11,356,312.00 | 2007-02-06 | 1203621071 | 3977072 | 5 | adar1-avoro-baker-ecor1-logos |
| 4 | INSM | 2025-06-30 | Insmed Incorporated | 72.65 | 13,209,223,168.00 | -5.34% | 166,410,802.00 | 2000-06-01 | 1093615731 | 10866611 | 6 | baker-cormorant-deeptrack-perceptive-orbimed-tang |
| 5 | ACAD | 2025-06-30 | ACADIA Pharmaceuticals Inc. | 14.73 | 2,456,801,792.00 | -17.66% | 114,380,229.00 | 2004-05-27 | 957636603 | 44396690 | 2 | baker-tang |
| 6 | RYTM | 2025-06-30 | Rhythm Pharmaceuticals, Inc. | 61.74 | 3,903,431,424.00 | 7.34% | 46,955,630.00 | 2017-10-09 | 915183487 | 14483043 | 7 | adar1-baker-logos-perceptive-racapital-orbimed-opaleye |
| 7 | KYMR | 2025-06-30 | Kymera Therapeutics, Inc. | 25.97 | 1,686,598,272.00 | -40.57% | 42,816,370.00 | 2020-08-21 | 826243364 | 18933166 | 5 | adar1-avoro-baker-bvf-perceptive |
| 8 | ARGX | 2025-06-30 | argenx SE | 596.20 | 36,474,028,032.00 | -7.91% | 60,989,637.00 | 2017-05-18 | 784120923 | 1422519 | 4 | adar1-avoro-baker-orbimed |
| 9 | SMMT | 2025-06-30 | Summit Therapeutics Inc. | 24.61 | 18,154,305,536.00 | 11.36% | 111,183,085.00 | 2015-03-05 | 723200247 | 33984974 | 3 | adar1-baker-tang |
| 10 | RVMD | 2025-06-30 | Revolution Medicines, Inc. | 36.76 | 6,834,161,152.00 | -8.47% | 168,212,518.00 | 2020-02-13 | 709106095 | 19274425 | 7 | adar1-baker-bvf-casdin-logos-opaleye-tang |
| 11 | UTHR | 2025-06-30 | United Therapeutics Corporation | 291.38 | 13,312,861,184.00 | -21.15% | 41,324,592.00 | 1999-06-17 | 705444250 | 2455000 | 2 | avoro-logos |
| 12 | VRNA | 2025-06-30 | Verona Pharma plc | 65.46 | 8,622,652,416.00 | 21.92% | 493,924,450.00 | 2017-04-28 | 596788829 | 6309884 | 5 | adar1-baker-cormorant-ecor1-perceptive |
| 13 | APLS | 2025-06-30 | Apellis Pharmaceuticals, Inc. | 18.20 | 2,284,391,168.00 | -39.60% | 84,226,131.00 | 2017-11-09 | 564605982 | 32617330 | 5 | adar1-avoro-deeptrack-ecor1-orbimed |
| 14 | EWTX | 2025-06-30 | Edgewise Therapeutics, Inc. | 11.42 | 1,200,710,272.00 | -54.92% | 54,187,991.00 | 2021-03-26 | 558227811 | 42580306 | 8 | adar1-baker-cormorant-perceptive-racapital-orbimed-opaleye-tang |
| 15 | RNA | 2025-06-30 | Avidity Biosciences, Inc. | 26.66 | 3,204,851,968.00 | -13.55% | 92,698,110.00 | 2020-06-12 | 555331242 | 19553917 | 7 | avoro-casdin-cormorant-ecor1-logos-racapital-orbimed |
| 16 | AKRO | 2025-06-30 | Akero Therapeutics, Inc. | 37.63 | 2,996,104,192.00 | 46.99% | 66,438,220.00 | 2019-06-20 | 515860894 | 9667558 | 8 | adar1-avoro-baker-deeptrack-ecor1-logos-perceptive-orbimed |
| 17 | PCVX | 2025-06-30 | Vaxcyte, Inc. | 30.65 | 3,946,555,136.00 | -65.24% | 119,134,116.00 | 2020-06-12 | 498375308 | 15329908 | 6 | adar1-baker-cormorant-deeptrack-racapital-tang |
| 18 | PTGX | 2025-06-30 | Protagonist Therapeutics, Inc. | 46.28 | 2,840,865,280.00 | 21.47% | 46,016,118.00 | 2016-08-11 | 474462939 | 8584457 | 5 | adar1-bvf-deeptrack-perceptive-opaleye |
| 19 | ACLX | 2025-06-30 | Arcellx, Inc. | 59.15 | 3,249,937,664.00 | -12.19% | 32,601,579.00 | 2022-02-04 | 427716427 | 6495314 | 5 | adar1-baker-cormorant-perceptive-racapital |
| 20 | JANX | 2025-06-30 | Janux Therapeutics, Inc. | 28.80 | 1,702,226,816.00 | -36.09% | 37,290,619.00 | 2021-06-11 | 390957914 | 16924585 | 8 | adar1-cormorant-ecor1-logos-perceptive-racapital-orbimed-tang |
| 21 | KRYS | 2025-06-30 | Krystal Biotech, Inc. | 168.57 | 4,871,403,520.00 | 11.23% | 22,823,920.00 | 2017-09-20 | 380654232 | 2769200 | 3 | avoro-logos-orbimed |
| 22 | ZYME | 2025-06-30 | Zymeworks Inc. | 10.63 | 739,602,432.00 | -23.85% | 38,672,223.00 | 2017-04-28 | 374800692 | 29864597 | 5 | bvf-ecor1-perceptive-opaleye-tang |
| 23 | ETNB | 2025-06-30 | 89bio, Inc. | 6.06 | 884,663,040.00 | -7.90% | 107,537,788.00 | 2019-11-11 | 363493840 | 37015666 | 4 | adar1-avoro-deeptrack-racapital |
| 24 | SPRY | 2025-06-30 | ARS Pharmaceuticals, Inc. | 14.05 | 1,378,583,168.00 | 24.78% | 47,452,700.00 | 2020-12-04 | 353353549 | 20249487 | 3 | cormorant-racapital-orbimed |
| 25 | MRUS | 2025-06-30 | Merus N.V. | 43.05 | 2,974,691,328.00 | 8.34% | 55,639,246.00 | 2016-05-19 | 339344745 | 6451421 | 7 | adar1-avoro-baker-cormorant-deeptrack-perceptive-tang |
| 26 | WGS | 2025-06-30 | GeneDx Holdings Corp. | 96.63 | 2,712,239,872.00 | 13.67% | 18,444,224.00 | 2020-11-04 | 338335351 | 3665208 | 3 | casdin-racapital-tang |
| 27 | AXSM | 2025-06-30 | Axsome Therapeutics, Inc. | 104.46 | 5,094,033,408.00 | 8.61% | 36,674,021.00 | 2015-11-19 | 335929734 | 3218026 | 5 | bvf-cormorant-deeptrack-perceptive-orbimed |
| 28 | BSX | 2025-06-30 | Boston Scientific Corporation | 93.67 | 138,544,480,256.00 | -0.99% | 1,471,454,074.00 | 1992-05-19 | 332240612 | 3093200 | 2 | perceptive-orbimed |
| 29 | GPCR | 2025-06-30 | Structure Therapeutics Inc. | 15.90 | 911,750,528.00 | -36.80% | 148,959,516.00 | 2023-02-03 | 294939787 | 14220819 | 8 | adar1-baker-bvf-casdin-deeptrack-logos-racapital-orbimed |
| 30 | IMVT | 2025-06-30 | Immunovant, Inc. | 15.15 | 2,573,393,920.00 | -35.78% | 62,221,667.00 | 2019-06-21 | 286493392 | 17905837 | 5 | adar1-baker-deeptrack-logos-perceptive |
| 31 | ALKS | 2025-06-30 | Alkermes plc | 27.00 | 4,450,571,776.00 | -10.30% | 160,028,503.00 | 1991-07-16 | 281968802 | 9855603 | 4 | adar1-avoro-baker-ecor1 |
| 32 | IONS | 2025-06-30 | Ionis Pharmaceuticals, Inc. | 28.40 | 4,514,605,568.00 | -13.10% | 157,589,727.00 | 1991-05-17 | 280654938 | 7103390 | 4 | adar1-bvf-deeptrack-tang |
| 33 | LLY | 2025-06-30 | Eli Lilly and Company | 839.96 | 754,274,861,056.00 | 13.15% | 895,933,556.00 | 1972-06-01 | 277980398 | 356600 | 4 | adar1-casdin-orbimed-tang |
| 34 | XENE | 2025-06-30 | Xenon Pharmaceuticals Inc. | 31.40 | 2,403,443,968.00 | -17.91% | 70,775,310.00 | 2014-11-05 | 266938262 | 8528379 | 6 | adar1-avoro-baker-deeptrack-perceptive-orbimed |
| 35 | GHRS | 2025-06-30 | GH Research PLC | 9.00 | 558,252,928.00 | 7.78% | 17,280,108.00 | 2021-06-25 | 250064331 | 20513891 | 4 | bvf-cormorant-deeptrack-racapital |
| 36 | JAZZ | 2025-06-30 | Jazz Pharmaceuticals plc | 102.78 | 6,242,086,400.00 | -15.36% | 58,903,824.00 | 2007-06-01 | 249299120 | 2349219 | 4 | adar1-ecor1-logos-tang |
| 37 | IMCR | 2025-06-30 | Immunocore Holdings plc | 26.59 | 1,312,099,456.00 | -11.46% | 37,260,699.00 | 2021-02-05 | 245628581 | 7827552 | 5 | baker-bvf-deeptrack-logos-tang |
| 38 | OCUL | 2025-06-30 | Ocular Therapeutix, Inc. | 7.31 | 1,162,450,816.00 | -9.64% | 124,121,633.00 | 2014-07-25 | 236541818 | 25489420 | 4 | avoro-deeptrack-logos-opaleye |
| 39 | CDTX | 2025-06-30 | Cidara Therapeutics, Inc. | 19.44 | 212,936,048.00 | -12.35% | 3,569,414.00 | 2015-04-15 | 235790935 | 4840709 | 6 | adar1-baker-bvf-deeptrack-logos-racapital |
New Positions (Not previously in any of the funds) Sorted by Value
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | Position | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | CAI | 2025-06-30 | None | NaN | NaN | -5.21% | NaN | 2025-06-18 09:30:00 | 110434321 | 4133021 | 2 | perceptive-orbimed | New |
| 1 | OMDA | 2025-06-30 | Omada Health, Inc. | 17.52 | 976,640,192.00 | -23.83% | 5,438,394.00 | 2025-06-06 09:30:00 | 51721839 | 2826330 | 2 | perceptive-racapital | New |
| 2 | CBIO | 2025-06-30 | Crescent Biopharma, Inc. | 15.09 | 294,255,008.00 | -20.58% | NaN | 2014-01-10 09:30:00 | 46791038 | 2899073 | 5 | bvf-deeptrack-logos-perceptive-tang | New |
| 3 | RAPT | 2025-06-30 | RAPT Therapeutics, Inc. | 0.79 | 104,351,528.00 | -34.13% | 58,439,423.00 | 2019-10-31 | 36121016 | 4515127 | 5 | adar1-bvf-deeptrack-perceptive-orbimed | New |
| 4 | MTD | 2025-06-30 | Mettler-Toledo International, I | 1,004.96 | 20,944,371,712.00 | -24.12% | 20,572,592.00 | 1997-11-14 | 22907040 | 19500 | 1 | tang | New |
| 5 | HNGE | 2025-06-30 | Hinge Health, Inc. | 46.95 | 3,662,846,720.00 | 25.00% | 4,695,728.00 | 2025-05-22 09:30:00 | 15525000 | 300000 | 1 | racapital | New |
| 6 | CRL | 2025-06-30 | Charles River Laboratories Inte | 106.05 | 5,208,720,384.00 | -37.55% | 50,549,899.00 | 2000-06-23 | 15173000 | 100000 | 1 | perceptive | New |
| 7 | PCRX | 2025-06-30 | Pacira BioSciences, Inc. | 24.65 | 1,140,708,352.00 | 7.92% | 43,487,172.00 | 2011-02-03 | 10933557 | 457471 | 1 | ecor1 | New |
| 8 | CPRX | 2025-06-30 | Catalyst Pharmaceuticals, Inc. | 22.52 | 2,746,516,736.00 | -1.75% | 113,799,541.00 | 2006-11-08 | 9046730 | 416900 | 1 | orbimed | New |
| 9 | PEN | 2025-06-30 | Penumbra, Inc. | 272.32 | 10,488,649,728.00 | 10.28% | 37,159,032.00 | 2015-09-18 | 8416694 | 32797 | 1 | perceptive | New |
| 10 | CABA | 2025-06-30 | Cabaletta Bio, Inc. | 1.10 | 55,817,412.00 | -57.69% | 42,831,744.00 | 2019-10-25 | 7600000 | 5000000 | 1 | cormorant | New |
| 11 | GMED | 2025-06-30 | Globus Medical, Inc. | 72.59 | 9,984,173,056.00 | -16.74% | 114,224,212.00 | 2012-08-03 | 5223270 | 88500 | 1 | perceptive | New |
| 12 | NVNO | 2025-06-30 | enVVeno Medical Corporation | 2.19 | 38,403,624.00 | -31.35% | 17,374,493.00 | 2018-05-31 | 5127014 | 1284966 | 1 | perceptive | New |
| 13 | BHC | 2025-06-30 | Bausch Health Companies Inc. | 5.10 | 1,884,669,312.00 | -31.73% | 276,207,976.00 | 1994-03-29 | 4907268 | 736827 | 1 | tang | New |
| 14 | LYRA | 2025-06-30 | Lyra Therapeutics, Inc. | 0.09 | 5,698,671.00 | -55.18% | 46,626,967.00 | 2020-05-01 | 2286144 | 255150 | 1 | perceptive | New |
| 15 | UNCY | 2025-06-30 | Unicycive Therapeutics, Inc. | 0.55 | 65,550,456.00 | -20.17% | 70,600,827.00 | 2021-07-12 | 2258891 | 473562 | 1 | logos | New |
| 16 | CRMD | 2025-06-30 | CorMedix Inc. | 7.67 | 499,944,416.00 | -38.59% | 60,890,203.00 | 2010-05-13 | 2156000 | 175000 | 1 | adar1 | New |
| 17 | IFRX | 2025-06-30 | InflaRx N.V. | 1.06 | 71,161,288.00 | -57.09% | 50,522,550.00 | 2017-11-07 | 1558854 | 1973233 | 1 | racapital | New |
| 18 | MURA | 2025-06-30 | Mural Oncology plc | 1.03 | 17,745,148.00 | -72.46% | 12,903,301.00 | 2023-11-24 | 1483618 | 600655 | 2 | adar1-orbimed | New |
| 19 | TRIB | 2025-06-30 | Trinity Biotech plc | 0.71 | 13,589,423.00 | -6.84% | 181,493,781.00 | 1992-10-21 | 1163500 | 1790000 | 1 | perceptive | New |
| 20 | BOLT | 2025-06-30 | Bolt Biotherapeutics, Inc. | 0.32 | 12,410,561.00 | -38.81% | 27,481,128.00 | 2021-02-05 | 1025341 | 177702 | 2 | adar1-tang | New |
| 21 | TPST | 2025-06-30 | Tempest Therapeutics, Inc. | 6.22 | 21,896,390.00 | -48.16% | 3,222,289.00 | 2012-11-12 | 944942 | 138962 | 1 | tang | New |
| 22 | MRK | 2025-06-30 | Merck & Company, Inc. | 78.00 | 196,278,419,456.00 | -18.95% | 2,522,019,842.00 | 1962-01-02 | 557286 | 7040 | 1 | adar1 | New |
| 23 | LUNG | 2025-06-30 | Pulmonx Corporation | 5.25 | 211,299,376.00 | -25.53% | 38,129,348.00 | 2020-10-01 | 529647 | 204497 | 1 | adar1 | New |
| 24 | LYEL | 2025-06-30 | Lyell Immunopharma, Inc. | 0.44 | 129,457,912.00 | -26.18% | 201,520,273.00 | 2021-06-17 | 457267 | 51727 | 1 | orbimed | New |
| 25 | NKTR | 2025-06-30 | Nektar Therapeutics | 0.64 | 118,436,584.00 | -29.29% | 173,991,966.00 | 1994-05-03 | 408169 | 15796 | 1 | adar1 | New |
| 26 | FENC | 2025-06-30 | Fennec Pharmaceuticals Inc. | 5.08 | 140,940,032.00 | -11.50% | 14,403,520.00 | 2017-09-15 | 170374 | 20527 | 1 | tang | New |
| 27 | MCRB | 2025-06-30 | Seres Therapeutics, Inc. | 0.37 | 64,512,832.00 | -49.38% | 128,451,837.00 | 2015-06-26 | 154662 | 13921 | 1 | tang | New |
| 28 | RLMD | 2025-06-30 | Relmada Therapeutics, Inc. | 0.29 | 9,618,925.00 | -21.89% | 30,568,156.00 | 2014-06-20 | 78039 | 130000 | 1 | adar1 | New |
| 29 | ACTU | 2025-06-30 | Actuate Therapeutics, Inc. | 7.66 | 149,612,048.00 | -5.20% | 5,962,227.00 | 2024-08-13 | 32035 | 5243 | 1 | tang | New |
| 30 | GALT | 2025-06-30 | Galectin Therapeutics Inc. | 1.38 | 87,189,088.00 | 12.20% | 44,013,425.00 | 2002-09-04 | 27246 | 12913 | 1 | tang | New |
| 31 | NERV | 2025-06-30 | Minerva Neurosciences, Inc | 1.60 | 11,189,456.00 | -26.77% | 5,437,023.00 | 2014-07-01 | 21338 | 12406 | 1 | adar1 | New |
------------------------------------------------------------ ------------------------------------------------------------ New Positions (Not previously in any of the funds) Sorted by Number of Funds initiating the new position
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | CBIO | 2025-06-30 | Crescent Biopharma, Inc. | 15.09 | 294,255,008.00 | -20.58% | NaN | 2014-01-10 09:30:00 | 46791038 | 2899073 | 5 | bvf-deeptrack-logos-perceptive-tang |
| 1 | RAPT | 2025-06-30 | RAPT Therapeutics, Inc. | 0.79 | 104,351,528.00 | -34.13% | 58,439,423.00 | 2019-10-31 | 36121016 | 4515127 | 5 | adar1-bvf-deeptrack-perceptive-orbimed |
| 2 | CAI | 2025-06-30 | None | NaN | NaN | -5.21% | NaN | 2025-06-18 09:30:00 | 110434321 | 4133021 | 2 | perceptive-orbimed |
| 3 | MURA | 2025-06-30 | Mural Oncology plc | 1.03 | 17,745,148.00 | -72.46% | 12,903,301.00 | 2023-11-24 | 1483618 | 600655 | 2 | adar1-orbimed |
| 4 | BOLT | 2025-06-30 | Bolt Biotherapeutics, Inc. | 0.32 | 12,410,561.00 | -38.81% | 27,481,128.00 | 2021-02-05 | 1025341 | 177702 | 2 | adar1-tang |
| 5 | OMDA | 2025-06-30 | Omada Health, Inc. | 17.52 | 976,640,192.00 | -23.83% | 5,438,394.00 | 2025-06-06 09:30:00 | 51721839 | 2826330 | 2 | perceptive-racapital |
| 6 | RLMD | 2025-06-30 | Relmada Therapeutics, Inc. | 0.29 | 9,618,925.00 | -21.89% | 30,568,156.00 | 2014-06-20 | 78039 | 130000 | 1 | adar1 |
| 7 | MCRB | 2025-06-30 | Seres Therapeutics, Inc. | 0.37 | 64,512,832.00 | -49.38% | 128,451,837.00 | 2015-06-26 | 154662 | 13921 | 1 | tang |
| 8 | ACTU | 2025-06-30 | Actuate Therapeutics, Inc. | 7.66 | 149,612,048.00 | -5.20% | 5,962,227.00 | 2024-08-13 | 32035 | 5243 | 1 | tang |
| 9 | NKTR | 2025-06-30 | Nektar Therapeutics | 0.64 | 118,436,584.00 | -29.29% | 173,991,966.00 | 1994-05-03 | 408169 | 15796 | 1 | adar1 |
| 10 | LYEL | 2025-06-30 | Lyell Immunopharma, Inc. | 0.44 | 129,457,912.00 | -26.18% | 201,520,273.00 | 2021-06-17 | 457267 | 51727 | 1 | orbimed |
| 11 | LUNG | 2025-06-30 | Pulmonx Corporation | 5.25 | 211,299,376.00 | -25.53% | 38,129,348.00 | 2020-10-01 | 529647 | 204497 | 1 | adar1 |
| 12 | MRK | 2025-06-30 | Merck & Company, Inc. | 78.00 | 196,278,419,456.00 | -18.95% | 2,522,019,842.00 | 1962-01-02 | 557286 | 7040 | 1 | adar1 |
| 13 | TPST | 2025-06-30 | Tempest Therapeutics, Inc. | 6.22 | 21,896,390.00 | -48.16% | 3,222,289.00 | 2012-11-12 | 944942 | 138962 | 1 | tang |
| 14 | GALT | 2025-06-30 | Galectin Therapeutics Inc. | 1.38 | 87,189,088.00 | 12.20% | 44,013,425.00 | 2002-09-04 | 27246 | 12913 | 1 | tang |
| 15 | TRIB | 2025-06-30 | Trinity Biotech plc | 0.71 | 13,589,423.00 | -6.84% | 181,493,781.00 | 1992-10-21 | 1163500 | 1790000 | 1 | perceptive |
| 16 | FENC | 2025-06-30 | Fennec Pharmaceuticals Inc. | 5.08 | 140,940,032.00 | -11.50% | 14,403,520.00 | 2017-09-15 | 170374 | 20527 | 1 | tang |
| 17 | CRMD | 2025-06-30 | CorMedix Inc. | 7.67 | 499,944,416.00 | -38.59% | 60,890,203.00 | 2010-05-13 | 2156000 | 175000 | 1 | adar1 |
| 18 | IFRX | 2025-06-30 | InflaRx N.V. | 1.06 | 71,161,288.00 | -57.09% | 50,522,550.00 | 2017-11-07 | 1558854 | 1973233 | 1 | racapital |
| 19 | UNCY | 2025-06-30 | Unicycive Therapeutics, Inc. | 0.55 | 65,550,456.00 | -20.17% | 70,600,827.00 | 2021-07-12 | 2258891 | 473562 | 1 | logos |
| 20 | LYRA | 2025-06-30 | Lyra Therapeutics, Inc. | 0.09 | 5,698,671.00 | -55.18% | 46,626,967.00 | 2020-05-01 | 2286144 | 255150 | 1 | perceptive |
| 21 | BHC | 2025-06-30 | Bausch Health Companies Inc. | 5.10 | 1,884,669,312.00 | -31.73% | 276,207,976.00 | 1994-03-29 | 4907268 | 736827 | 1 | tang |
| 22 | NVNO | 2025-06-30 | enVVeno Medical Corporation | 2.19 | 38,403,624.00 | -31.35% | 17,374,493.00 | 2018-05-31 | 5127014 | 1284966 | 1 | perceptive |
| 23 | GMED | 2025-06-30 | Globus Medical, Inc. | 72.59 | 9,984,173,056.00 | -16.74% | 114,224,212.00 | 2012-08-03 | 5223270 | 88500 | 1 | perceptive |
| 24 | CABA | 2025-06-30 | Cabaletta Bio, Inc. | 1.10 | 55,817,412.00 | -57.69% | 42,831,744.00 | 2019-10-25 | 7600000 | 5000000 | 1 | cormorant |
| 25 | PEN | 2025-06-30 | Penumbra, Inc. | 272.32 | 10,488,649,728.00 | 10.28% | 37,159,032.00 | 2015-09-18 | 8416694 | 32797 | 1 | perceptive |
| 26 | CPRX | 2025-06-30 | Catalyst Pharmaceuticals, Inc. | 22.52 | 2,746,516,736.00 | -1.75% | 113,799,541.00 | 2006-11-08 | 9046730 | 416900 | 1 | orbimed |
| 27 | PCRX | 2025-06-30 | Pacira BioSciences, Inc. | 24.65 | 1,140,708,352.00 | 7.92% | 43,487,172.00 | 2011-02-03 | 10933557 | 457471 | 1 | ecor1 |
| 28 | CRL | 2025-06-30 | Charles River Laboratories Inte | 106.05 | 5,208,720,384.00 | -37.55% | 50,549,899.00 | 2000-06-23 | 15173000 | 100000 | 1 | perceptive |
| 29 | HNGE | 2025-06-30 | Hinge Health, Inc. | 46.95 | 3,662,846,720.00 | 25.00% | 4,695,728.00 | 2025-05-22 09:30:00 | 15525000 | 300000 | 1 | racapital |
| 30 | MTD | 2025-06-30 | Mettler-Toledo International, I | 1,004.96 | 20,944,371,712.00 | -24.12% | 20,572,592.00 | 1997-11-14 | 22907040 | 19500 | 1 | tang |
| 31 | NERV | 2025-06-30 | Minerva Neurosciences, Inc | 1.60 | 11,189,456.00 | -26.77% | 5,437,023.00 | 2014-07-01 | 21338 | 12406 | 1 | adar1 |
------------------------------------------------------------ ------------------------------------------------------------ Increased Positions (when all funds shares were added together) Sorted by Value
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | Position | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | ASND | 2025-06-30 | Ascendis Pharma A/S | 165.05 | 9,923,581,952.00 | 25.93% | 59,372,631.00 | 2015-01-28 | 2806680359 | 16261184 | 5 | adar1-avoro-perceptive-racapital-orbimed | 4.90% | Increased |
| 1 | INCY | 2025-06-30 | Incyte Corporation | 58.21 | 11,265,032,192.00 | -20.77% | 161,370,279.00 | 1993-11-04 | 2093617028 | 30743275 | 1 | baker | 0.01% | Increased |
| 2 | MLTX | 2025-06-30 | MoonLake Immunotherapeutics | 34.90 | 2,208,566,272.00 | -22.88% | 28,073,483.00 | 2020-10-20 | 1540124153 | 32629749 | 5 | adar1-avoro-bvf-cormorant-logos | 4.01% | Increased |
| 3 | INSM | 2025-06-30 | Insmed Incorporated | 72.65 | 13,209,223,168.00 | -5.34% | 166,410,802.00 | 2000-06-01 | 1093615731 | 10866611 | 6 | baker-cormorant-deeptrack-perceptive-orbimed-tang | 55.14% | Increased |
| 4 | ACAD | 2025-06-30 | ACADIA Pharmaceuticals Inc. | 14.73 | 2,456,801,792.00 | -17.66% | 114,380,229.00 | 2004-05-27 | 957636603 | 44396690 | 2 | baker-tang | 0.04% | Increased |
| 5 | KYMR | 2025-06-30 | Kymera Therapeutics, Inc. | 25.97 | 1,686,598,272.00 | -40.57% | 42,816,370.00 | 2020-08-21 | 826243364 | 18933166 | 5 | adar1-avoro-baker-bvf-perceptive | 7.41% | Increased |
| 6 | SMMT | 2025-06-30 | Summit Therapeutics Inc. | 24.61 | 18,154,305,536.00 | 11.36% | 111,183,085.00 | 2015-03-05 | 723200247 | 33984974 | 3 | adar1-baker-tang | 39.14% | Increased |
| 7 | RVMD | 2025-06-30 | Revolution Medicines, Inc. | 36.76 | 6,834,161,152.00 | -8.47% | 168,212,518.00 | 2020-02-13 | 709106095 | 19274425 | 7 | adar1-baker-bvf-casdin-logos-opaleye-tang | 4.22% | Increased |
| 8 | APLS | 2025-06-30 | Apellis Pharmaceuticals, Inc. | 18.20 | 2,284,391,168.00 | -39.60% | 84,226,131.00 | 2017-11-09 | 564605982 | 32617330 | 5 | adar1-avoro-deeptrack-ecor1-orbimed | 6.71% | Increased |
| 9 | RNA | 2025-06-30 | Avidity Biosciences, Inc. | 26.66 | 3,204,851,968.00 | -13.55% | 92,698,110.00 | 2020-06-12 | 555331242 | 19553917 | 7 | avoro-casdin-cormorant-ecor1-logos-racapital-orbimed | 2.43% | Increased |
| 10 | AKRO | 2025-06-30 | Akero Therapeutics, Inc. | 37.63 | 2,996,104,192.00 | 46.99% | 66,438,220.00 | 2019-06-20 | 515860894 | 9667558 | 8 | adar1-avoro-baker-deeptrack-ecor1-logos-perceptive-orbimed | 50.05% | Increased |
| 11 | PTGX | 2025-06-30 | Protagonist Therapeutics, Inc. | 46.28 | 2,840,865,280.00 | 21.47% | 46,016,118.00 | 2016-08-11 | 474462939 | 8584457 | 5 | adar1-bvf-deeptrack-perceptive-opaleye | 11.33% | Increased |
| 12 | KRYS | 2025-06-30 | Krystal Biotech, Inc. | 168.57 | 4,871,403,520.00 | 11.23% | 22,823,920.00 | 2017-09-20 | 380654232 | 2769200 | 3 | avoro-logos-orbimed | 0.53% | Increased |
| 13 | ZYME | 2025-06-30 | Zymeworks Inc. | 10.63 | 739,602,432.00 | -23.85% | 38,672,223.00 | 2017-04-28 | 374800692 | 29864597 | 5 | bvf-ecor1-perceptive-opaleye-tang | 20.63% | Increased |
| 14 | MRUS | 2025-06-30 | Merus N.V. | 43.05 | 2,974,691,328.00 | 8.34% | 55,639,246.00 | 2016-05-19 | 339344745 | 6451421 | 7 | adar1-avoro-baker-cormorant-deeptrack-perceptive-tang | 33.82% | Increased |
| 15 | WGS | 2025-06-30 | GeneDx Holdings Corp. | 96.63 | 2,712,239,872.00 | 13.67% | 18,444,224.00 | 2020-11-04 | 338335351 | 3665208 | 3 | casdin-racapital-tang | 4.51% | Increased |
| 16 | AXSM | 2025-06-30 | Axsome Therapeutics, Inc. | 104.46 | 5,094,033,408.00 | 8.61% | 36,674,021.00 | 2015-11-19 | 335929734 | 3218026 | 5 | bvf-cormorant-deeptrack-perceptive-orbimed | 19.98% | Increased |
| 17 | BSX | 2025-06-30 | Boston Scientific Corporation | 93.67 | 138,544,480,256.00 | -0.99% | 1,471,454,074.00 | 1992-05-19 | 332240612 | 3093200 | 2 | perceptive-orbimed | 5.10% | Increased |
| 18 | GPCR | 2025-06-30 | Structure Therapeutics Inc. | 15.90 | 911,750,528.00 | -36.80% | 148,959,516.00 | 2023-02-03 | 294939787 | 14220819 | 8 | adar1-baker-bvf-casdin-deeptrack-logos-racapital-orbimed | 48.71% | Increased |
| 19 | ALKS | 2025-06-30 | Alkermes plc | 27.00 | 4,450,571,776.00 | -10.30% | 160,028,503.00 | 1991-07-16 | 281968802 | 9855603 | 4 | adar1-avoro-baker-ecor1 | 42.15% | Increased |
| 20 | LLY | 2025-06-30 | Eli Lilly and Company | 839.96 | 754,274,861,056.00 | 13.15% | 895,933,556.00 | 1972-06-01 | 277980398 | 356600 | 4 | adar1-casdin-orbimed-tang | 5.44% | Increased |
| 21 | GHRS | 2025-06-30 | GH Research PLC | 9.00 | 558,252,928.00 | 7.78% | 17,280,108.00 | 2021-06-25 | 250064331 | 20513891 | 4 | bvf-cormorant-deeptrack-racapital | 3.70% | Increased |
| 22 | JAZZ | 2025-06-30 | Jazz Pharmaceuticals plc | 102.78 | 6,242,086,400.00 | -15.36% | 58,903,824.00 | 2007-06-01 | 249299120 | 2349219 | 4 | adar1-ecor1-logos-tang | 23.87% | Increased |
| 23 | IMCR | 2025-06-30 | Immunocore Holdings plc | 26.59 | 1,312,099,456.00 | -11.46% | 37,260,699.00 | 2021-02-05 | 245628581 | 7827552 | 5 | baker-bvf-deeptrack-logos-tang | 38.55% | Increased |
| 24 | CDTX | 2025-06-30 | Cidara Therapeutics, Inc. | 19.44 | 212,936,048.00 | -12.35% | 3,569,414.00 | 2015-04-15 | 235790935 | 4840709 | 6 | adar1-baker-bvf-deeptrack-logos-racapital | 137.48% | Increased |
| 25 | IRON | 2025-06-30 | Disc Medicine, Inc. | 38.73 | 1,338,857,344.00 | -34.07% | 26,301,510.00 | 2020-08-12 | 223257858 | 4215594 | 5 | baker-logos-racapital-orbimed-opaleye | 13.98% | Increased |
| 26 | ELVN | 2025-06-30 | Enliven Therapeutics, Inc. | 16.51 | 809,062,656.00 | -25.19% | 26,934,302.00 | 2020-03-12 | 190035541 | 9473357 | 5 | baker-cormorant-logos-racapital-orbimed | 0.64% | Increased |
| 27 | ARWR | 2025-06-30 | Arrowhead Pharmaceuticals, Inc. | 11.24 | 1,543,442,944.00 | -43.12% | 108,000,510.00 | 1993-12-16 | 183191109 | 11594374 | 3 | adar1-avoro-baker | 3.82% | Increased |
| 28 | ISRG | 2025-06-30 | Intuitive Surgical, Inc. | 493.60 | 176,844,554,240.00 | -8.55% | 354,513,456.00 | 2000-06-16 | 182650426 | 336119 | 2 | perceptive-orbimed | 1.14% | Increased |
| 29 | VERA | 2025-06-30 | Vera Therapeutics, Inc. | 22.43 | 1,430,399,232.00 | -35.49% | 50,541,557.00 | 2021-05-14 | 180234000 | 7650000 | 2 | avoro-tang | 20.80% | Increased |
| 30 | CYTK | 2025-06-30 | Cytokinetics, Incorporated | 39.48 | 4,705,542,144.00 | -13.84% | 117,836,397.00 | 2004-04-30 | 178718217 | 5409147 | 4 | adar1-deeptrack-orbimed-tang | 6.61% | Increased |
| 31 | RARE | 2025-06-30 | Ultragenyx Pharmaceutical Inc. | 35.69 | 3,351,280,128.00 | -13.54% | 89,184,961.00 | 2014-01-31 | 171717081 | 4722692 | 4 | avoro-baker-deeptrack-perceptive | 25.73% | Increased |
| 32 | TYRA | 2025-06-30 | Tyra Biosciences, Inc. | 7.96 | 422,596,416.00 | -47.28% | 21,075,120.00 | 2021-09-15 | 162288338 | 16958029 | 4 | baker-bvf-racapital-orbimed | 3.75% | Increased |
| 33 | ITOS | 2025-06-30 | iTeos Therapeutics, Inc. | 6.51 | 248,644,896.00 | -19.23% | 29,147,629.00 | 2020-07-24 | 151968792 | 15242607 | 4 | adar1-ecor1-orbimed-tang | 60.21% | Increased |
| 34 | LENZ | 2025-06-30 | LENZ Therapeutics, Inc. | 20.26 | 558,023,232.00 | -12.67% | 11,210,776.00 | 2021-06-25 | 148790427 | 5076439 | 2 | racapital-tang | 2.64% | Increased |
| 35 | VRDN | 2025-06-30 | Viridian Therapeutics, Inc. | 12.02 | 979,449,728.00 | -32.36% | 76,929,941.00 | 2014-06-18 | 147990673 | 10585885 | 5 | adar1-baker-deeptrack-perceptive-tang | 18.78% | Increased |
| 36 | KNSA | 2025-06-30 | Kiniksa Pharmaceuticals, Ltd. | 20.21 | 1,468,139,264.00 | 8.02% | 23,218,552.00 | 2018-05-25 | 144155664 | 5209818 | 3 | adar1-baker-tang | 3.35% | Increased |
| 37 | CELC | 2025-06-30 | Celcuity Inc. | 10.24 | 387,475,456.00 | -8.65% | 20,768,907.00 | 2017-09-20 | 140837868 | 10549653 | 3 | baker-bvf-perceptive | 4.60% | Increased |
| 38 | REPL | 2025-06-30 | Replimune Group, Inc. | 8.00 | 615,733,312.00 | -32.53% | 53,003,113.00 | 2018-07-20 | 140335455 | 15106077 | 4 | adar1-baker-ecor1-tang | 2.10% | Increased |
| 39 | PRAX | 2025-06-30 | Praxis Precision Medicines, Inc | 29.74 | 599,653,568.00 | -53.55% | 16,083,216.00 | 2020-10-16 | 138445798 | 3292409 | 4 | baker-cormorant-logos-perceptive | 7.69% | Increased |
| 40 | EW | 2025-06-30 | Edwards Lifesciences Corporatio | 69.40 | 40,651,399,168.00 | -2.38% | 581,838,751.00 | 2000-03-27 | 133582680 | 1708000 | 1 | orbimed | 11.49% | Increased |
| 41 | ROIV | 2025-06-30 | Roivant Sciences Ltd. | 9.86 | 7,035,592,704.00 | -8.19% | 370,553,369.00 | 2020-12-08 | 133205337 | 11819462 | 4 | adar1-baker-perceptive-orbimed | 63.00% | Increased |
| 42 | KROS | 2025-06-30 | Keros Therapeutics, Inc. | 14.07 | 570,707,328.00 | 23.31% | 30,728,590.00 | 2020-04-08 | 131190209 | 9826982 | 4 | adar1-logos-orbimed-tang | 69.64% | Increased |
| 43 | TSHA | 2025-06-30 | Taysha Gene Therapies, Inc. | 1.25 | 255,227,488.00 | -25.45% | 127,701,667.00 | 2020-09-24 | 122823333 | 53170274 | 5 | adar1-avoro-baker-racapital-tang | 47.93% | Increased |
| 44 | WVE | 2025-06-30 | Wave Life Sciences Ltd. | 6.73 | 1,042,167,424.00 | -44.84% | 70,126,228.00 | 2015-11-11 | 121295760 | 18660886 | 3 | adar1-baker-racapital | 0.49% | Increased |
| 45 | DNTH | 2025-06-30 | Dianthus Therapeutics, Inc. | 17.61 | 565,737,088.00 | -23.57% | 14,121,907.00 | 2018-06-21 | 114655205 | 6154332 | 4 | baker-deeptrack-racapital-tang | 11.75% | Increased |
| 46 | QURE | 2025-06-30 | uniQure N.V. | 13.00 | 702,999,680.00 | -12.81% | 44,295,995.00 | 2014-02-05 | 106138756 | 7613971 | 2 | avoro-ecor1 | 23.52% | Increased |
| 47 | UNH | 2025-06-30 | UnitedHealth Group Incorporated | 599.47 | 548,342,366,208.00 | 10.78% | 912,224,315.00 | 1984-10-17 | 105764335 | 339021 | 2 | orbimed-tang | 65.59% | Increased |
| 48 | NTRA | 2025-06-30 | Natera, Inc. | 148.08 | 20,018,343,936.00 | -11.57% | 130,699,355.00 | 2015-07-01 | 100677090 | 595934 | 2 | adar1-orbimed | 8.11% | Increased |
| 49 | MLYS | 2025-06-30 | Mineralys Therapeutics, Inc. | 13.40 | 869,341,056.00 | 43.16% | 33,142,194.00 | 2023-02-10 | 100253998 | 7409756 | 4 | adar1-racapital-orbimed-tang | 12.09% | Increased |
| 50 | VRTX | 2025-06-30 | Vertex Pharmaceuticals Incorpor | 493.84 | 126,956,879,872.00 | 11.26% | 256,181,277.00 | 1991-07-24 | 98071772 | 220287 | 2 | orbimed-tang | 37.77% | Increased |
| 51 | XNCR | 2025-06-30 | Xencor, Inc. | 8.54 | 601,744,640.00 | -57.85% | 63,604,579.00 | 2013-12-03 | 89923148 | 11440604 | 6 | adar1-baker-bvf-deeptrack-ecor1-logos | 3.27% | Increased |
| 52 | AUPH | 2025-06-30 | Aurinia Pharmaceuticals Inc | 7.75 | 1,064,377,344.00 | 0.26% | 133,424,854.00 | 2014-09-03 | 85034565 | 10039500 | 2 | adar1-tang | 0.10% | Increased |
| 53 | SYRE | 2025-06-30 | Spyre Therapeutics, Inc. | 12.22 | 736,340,544.00 | -43.29% | 46,620,133.00 | 2016-04-07 | 83969934 | 5609214 | 5 | adar1-baker-deeptrack-perceptive-tang | 22.01% | Increased |
| 54 | MGTX | 2025-06-30 | MeiraGTx Holdings plc | 5.41 | 426,604,960.00 | -15.60% | 31,284,119.00 | 2018-06-08 | 82231024 | 12626103 | 1 | perceptive | 0.36% | Increased |
| 55 | TRML | 2025-06-30 | Tourmaline Bio, Inc. | 13.10 | 336,478,752.00 | -32.72% | 15,577,956.00 | 2021-05-07 | 81460735 | 5094480 | 2 | avoro-racapital | 2.63% | Increased |
| 56 | CTMX | 2025-06-30 | CytomX Therapeutics, Inc. | 0.66 | 52,545,540.00 | -24.68% | 73,975,451.00 | 2015-10-08 | 81147458 | 35747779 | 6 | adar1-baker-perceptive-racapital-orbimed-tang | 175.12% | Increased |
| 57 | RLAY | 2025-06-30 | Relay Therapeutics, Inc. | 2.69 | 456,014,176.00 | -42.27% | 119,707,854.00 | 2020-07-16 | 71368552 | 20626749 | 3 | baker-casdin-tang | 8.74% | Increased |
| 58 | ETON | 2025-06-30 | Eton Pharmaceuticals, Inc. | 14.34 | 384,562,944.00 | -6.09% | 20,737,195.00 | 2018-11-13 | 69690252 | 4890544 | 2 | ecor1-opaleye | 2.07% | Increased |
| 59 | BNTX | 2025-06-30 | BioNTech SE | 98.76 | 23,741,212,672.00 | -15.77% | 92,355,164.00 | 2019-10-10 | 68026132 | 638923 | 2 | baker-tang | 22.86% | Increased |
| 60 | STOK | 2025-06-30 | Stoke Therapeutics, Inc. | 7.69 | 415,857,504.00 | -21.53% | 37,143,295.00 | 2019-06-19 | 67843535 | 5977404 | 5 | adar1-baker-cormorant-opaleye-tang | 4.54% | Increased |
| 61 | CLDX | 2025-06-30 | Celldex Therapeutics, Inc. | 18.30 | 1,214,823,552.00 | -25.64% | 57,785,116.00 | 1986-05-15 | 67619713 | 3322836 | 4 | adar1-baker-deeptrack-logos | 46.88% | Increased |
| 62 | ABVX | 2025-06-30 | Abivax SA | 5.97 | 378,736,480.00 | -8.12% | 30,875,904.00 | 2023-10-20 | 66413353 | 8681484 | 3 | adar1-cormorant-deeptrack | 9.63% | Increased |
| 63 | TNGX | 2025-06-30 | Tango Therapeutics, Inc. | 1.41 | 152,432,272.00 | -50.70% | 46,645,311.00 | 2020-09-03 | 64669368 | 12630736 | 2 | ecor1-racapital | 11.31% | Increased |
| 64 | ILMN | 2025-06-30 | Illumina, Inc. | 71.20 | 11,268,325,376.00 | -49.61% | 157,885,200.00 | 2000-07-28 | 61539450 | 645000 | 1 | casdin | 8.40% | Increased |
| 65 | TERN | 2025-06-30 | Terns Pharmaceuticals, Inc. | 2.14 | 186,816,880.00 | -55.42% | 53,712,485.00 | 2021-02-05 | 56272220 | 15086386 | 3 | adar1-deeptrack-orbimed | 14.82% | Increased |
| 66 | PTCT | 2025-06-30 | PTC Therapeutics, Inc. | 47.39 | 3,737,620,736.00 | 4.73% | 63,207,489.00 | 2013-06-20 | 53724000 | 1100000 | 1 | tang | 4.76% | Increased |
| 67 | TECX | 2025-06-30 | Tectonic Therapeutic, Inc. | 16.16 | 301,589,216.00 | -57.28% | 9,868,448.00 | 2018-06-21 | 53444934 | 2689730 | 5 | adar1-baker-deeptrack-ecor1-tang | 0.41% | Increased |
| 68 | CDXS | 2025-06-30 | Codexis, Inc. | 2.11 | 174,786,688.00 | -58.22% | 63,397,051.00 | 2010-04-22 | 48312000 | 19800000 | 2 | casdin-opaleye | 12.50% | Increased |
| 69 | ARVN | 2025-06-30 | Arvinas, Inc. | 8.60 | 591,438,400.00 | -53.69% | 53,685,383.00 | 2018-09-27 | 47858893 | 6502567 | 4 | adar1-logos-opaleye-tang | 76.60% | Increased |
| 70 | LQDA | 2025-06-30 | Liquidia Corporation | 13.72 | 1,170,295,424.00 | 0.73% | 66,205,312.00 | 2018-07-26 | 45089737 | 3618759 | 2 | opaleye-tang | 4.59% | Increased |
| 71 | RAPP | 2025-06-30 | Rapport Therapeutics, Inc. | 9.26 | 337,956,672.00 | -33.72% | 14,741,641.00 | 2024-06-07 | 43185057 | 3798158 | 4 | baker-cormorant-deeptrack-logos | 5.29% | Increased |
| 72 | TVTX | 2025-06-30 | Travere Therapeutics, Inc. | 14.50 | 1,287,189,632.00 | -22.00% | 75,506,943.00 | 2012-11-08 | 39726930 | 2684252 | 3 | perceptive-racapital-tang | 133.41% | Increased |
| 73 | LEGN | 2025-06-30 | Legend Biotech Corporation | 32.80 | 6,023,686,656.00 | -5.39% | 161,989,576.00 | 2020-06-05 | 38329200 | 1080000 | 2 | logos-tang | 30.12% | Increased |
| 74 | CRVS | 2025-06-30 | Corvus Pharmaceuticals, Inc. | 3.24 | 220,760,000.00 | -37.93% | 52,153,182.00 | 2016-03-23 | 34414404 | 8603601 | 2 | perceptive-orbimed | 23.91% | Increased |
| 75 | FDMT | 2025-06-30 | 4D Molecular Therapeutics, Inc. | 2.63 | 121,775,320.00 | -44.75% | 34,309,158.00 | 2020-12-11 | 34104175 | 9192500 | 2 | bvf-racapital | 0.75% | Increased |
| 76 | SNWV | 2025-06-30 | SANUWAVE Health, Inc. | 29.92 | 255,770,224.00 | 10.81% | 5,600,874.00 | 2025-03-03 | 32202800 | 980000 | 1 | opaleye | 0.82% | Increased |
| 77 | BIIB | 2025-06-30 | Biogen Inc. | 118.61 | 17,361,539,072.00 | -15.87% | 146,001,681.00 | 1991-09-17 | 30154159 | 240100 | 3 | adar1-logos-tang | 507.85% | Increased |
| 78 | LRMR | 2025-06-30 | Larimar Therapeutics, Inc. | 1.91 | 122,293,288.00 | -44.31% | 31,346,135.00 | 2014-06-19 | 30035642 | 10392956 | 3 | adar1-racapital-opaleye | 30.57% | Increased |
| 79 | AGIO | 2025-06-30 | Agios Pharmaceuticals, Inc. | 27.66 | 1,584,812,928.00 | -16.76% | 50,708,827.00 | 2013-07-24 | 29390731 | 883666 | 4 | adar1-baker-casdin-orbimed | 46.45% | Increased |
| 80 | ELDN | 2025-06-30 | Eledon Pharmaceuticals, Inc. | 2.94 | 176,052,496.00 | -24.42% | 46,043,696.00 | 2014-09-17 | 26765369 | 9876520 | 3 | adar1-bvf-racapital | 0.00% | Increased |
| 81 | PHVS | 2025-06-30 | Pharvaris N.V. | 12.00 | 653,917,184.00 | -26.87% | 19,413,727.00 | 2021-02-05 | 26202598 | 1488784 | 2 | adar1-cormorant | 1.52% | Increased |
| 82 | DSGN | 2025-06-30 | Design Therapeutics, Inc. | 2.89 | 164,044,208.00 | -29.60% | 25,381,999.00 | 2021-03-29 | 26130616 | 7753892 | 4 | adar1-baker-logos-tang | 1.46% | Increased |
| 83 | EPIX | 2025-06-30 | ESSA Pharma Inc. | 1.79 | 79,455,592.00 | 2.87% | 28,160,984.00 | 2015-03-13 | 26024666 | 15308627 | 4 | adar1-bvf-opaleye-tang | 0.33% | Increased |
| 84 | ALMS | 2025-06-30 | Alumis Inc. | 6.48 | 352,559,296.00 | -10.00% | 4,764,450.00 | 2024-06-28 | 25337712 | 8445904 | 6 | adar1-baker-cormorant-orbimed-opaleye-tang | 127.66% | Increased |
| 85 | NTLA | 2025-06-30 | Intellia Therapeutics, Inc. | 7.23 | 748,427,904.00 | -27.26% | 97,913,025.00 | 2016-05-06 | 25097822 | 2675674 | 1 | baker | 1.19% | Increased |
| 86 | TRVI | 2025-06-30 | Trevi Therapeutics, Inc. | 6.47 | 625,533,824.00 | 62.97% | 73,666,058.00 | 2019-05-07 | 25043848 | 4578400 | 4 | adar1-logos-orbimed-opaleye | 95.68% | Increased |
| 87 | FBRX | 2025-06-30 | Forte Biosciences, Inc. | 7.34 | 48,309,460.00 | -50.07% | 3,572,266.00 | 2017-04-13 | 23965639 | 1853491 | 3 | bvf-perceptive-orbimed | 56.10% | Increased |
| 88 | MNPR | 2025-06-30 | Monopar Therapeutics Inc. | 39.59 | 241,997,440.00 | 24.97% | 3,503,249.00 | 2019-12-19 | 21903836 | 612181 | 2 | adar1-racapital | 0.03% | Increased |
| 89 | ERAS | 2025-06-30 | Erasca, Inc. | 1.24 | 351,249,824.00 | -42.33% | 201,634,202.00 | 2021-07-16 | 20958702 | 16502915 | 2 | logos-tang | 16.30% | Increased |
| 90 | RGEN | 2025-06-30 | Repligen Corporation | 130.00 | 7,303,283,200.00 | -22.58% | 52,524,167.00 | 1986-04-29 | 20647080 | 166000 | 1 | perceptive | 27.89% | Increased |
| 91 | MNMD | 2025-06-30 | Mind Medicine (MindMed) Inc. | 5.43 | 409,250,400.00 | -16.40% | 70,224,468.00 | 2016-11-15 | 20120298 | 3100200 | 2 | deeptrack-tang | 6.90% | Increased |
| 92 | ABOS | 2025-06-30 | Acumen Pharmaceuticals, Inc. | 1.11 | 67,236,472.00 | -30.19% | 32,793,241.00 | 2021-07-01 | 18383965 | 15848246 | 2 | adar1-racapital | 5.11% | Increased |
| 93 | AVIR | 2025-06-30 | Atea Pharmaceuticals, Inc. | 2.71 | 231,773,296.00 | -15.31% | 66,621,549.00 | 2020-10-30 | 17601120 | 4889200 | 1 | tang | 1.86% | Increased |
| 94 | HLVX | 2025-06-30 | HilleVax, Inc. | 1.67 | 83,735,632.00 | -16.50% | 30,028,884.00 | 2022-04-29 | 14607084 | 7340243 | 2 | ecor1-tang | 49.19% | Increased |
| 95 | DERM | 2025-06-30 | Journey Medical Corporation | 6.03 | 139,319,536.00 | 59.52% | 10,945,727.00 | 2021-11-12 | 13998099 | 1949596 | 2 | opaleye-tang | 1.33% | Increased |
| 96 | BHVN | 2025-06-30 | Biohaven Ltd. | 20.37 | 2,079,064,192.00 | -47.81% | 84,648,084.00 | 2022-09-23 | 12449832 | 882341 | 4 | adar1-cormorant-logos-tang | 411.08% | Increased |
| 97 | VYGR | 2025-06-30 | Voyager Therapeutics, Inc. | 3.47 | 195,256,208.00 | -38.37% | 45,086,359.00 | 2015-11-11 | 12432197 | 3997491 | 2 | adar1-ecor1 | 0.11% | Increased |
| 98 | ABUS | 2025-06-30 | Arbutus Biopharma Corporation | 3.15 | 603,162,048.00 | -1.87% | 136,309,001.00 | 2007-07-26 | 8731639 | 2825773 | 1 | adar1 | 50.38% | Increased |
| 99 | IDXX | 2025-06-30 | IDEXX Laboratories, Inc. | 411.49 | 33,346,738,176.00 | -3.71% | 80,436,876.00 | 1991-06-21 | 8581440 | 16000 | 1 | tang | 220.00% | Increased |
| 100 | RZLT | 2025-06-30 | Rezolute, Inc. | 2.75 | 166,472,352.00 | -44.11% | 52,813,526.00 | 2013-01-14 | 8441616 | 1892739 | 2 | adar1-opaleye | 19.71% | Increased |
| 101 | SVRA | 2025-06-30 | Savara, Inc. | 3.01 | 519,625,312.00 | 7.50% | 101,850,947.00 | 2017-04-28 | 8209528 | 3600670 | 1 | adar1 | 164.70% | Increased |
| 102 | SNDX | 2025-06-30 | Syndax Pharmaceuticals, Inc. | 11.54 | 992,947,776.00 | -15.58% | 76,941,078.00 | 2016-03-02 | 8050650 | 860000 | 3 | adar1-casdin-tang | 2.99% | Increased |
| 103 | HOWL | 2025-06-30 | Werewolf Therapeutics, Inc. | 0.71 | 31,827,312.00 | -47.41% | 26,381,231.00 | 2021-04-30 | 7282625 | 6681307 | 1 | racapital | 8.73% | Increased |
| 104 | REGN | 2025-06-30 | Regeneron Pharmaceuticals, Inc. | 563.16 | 61,567,463,424.00 | -18.12% | 102,996,273.00 | 1991-04-02 | 7014525 | 13361 | 2 | adar1-tang | 17.60% | Increased |
| 105 | ANIK | 2025-06-30 | Anika Therapeutics Inc. | 14.02 | 198,747,520.00 | -15.03% | 10,199,202.00 | 1993-05-03 | 6229472 | 588797 | 1 | opaleye | 49.06% | Increased |
| 106 | IGMS | 2025-06-30 | IGM Biosciences, Inc. | 1.22 | 72,925,992.00 | -28.65% | 10,672,898.00 | 2019-09-18 | 4587755 | 4096210 | 1 | baker | 0.02% | Increased |
| 107 | ZNTL | 2025-06-30 | Zentalis Pharmaceuticals, Inc. | 1.23 | 88,328,152.00 | -51.95% | 45,013,608.00 | 2020-04-03 | 4088188 | 3524300 | 3 | adar1-opaleye-tang | 1.13% | Increased |
| 108 | CHRS | 2025-06-30 | Coherus BioSciences, Inc. | 1.12 | 129,804,640.00 | -15.15% | 114,413,369.00 | 2014-11-06 | 3735282 | 5107728 | 2 | adar1-tang | 0.20% | Increased |
| 109 | ARDX | 2025-06-30 | Ardelyx, Inc. | 4.82 | 1,147,684,096.00 | -1.93% | 231,291,344.00 | 2014-06-19 | 3587310 | 915130 | 1 | adar1 | 86.48% | Increased |
| 110 | TBPH | 2025-06-30 | Theravance Biopharma, Inc. | 8.62 | 431,011,200.00 | -5.79% | 21,119,514.00 | 2014-05-16 | 2915317 | 264308 | 1 | tang | 0.54% | Increased |
| 111 | TENX | 2025-06-30 | Tenax Therapeutics, Inc. | 5.32 | 21,095,822.00 | -17.52% | 3,915,154.00 | 1994-04-04 | 2878974 | 495106 | 2 | adar1-bvf | 21.26% | Increased |
| 112 | SEER | 2025-06-30 | Seer, Inc. | 2.00 | 119,564,000.00 | -13.79% | 41,961,608.00 | 2020-12-04 | 2877065 | 1344423 | 1 | tang | 3.86% | Increased |
| 113 | PYXS | 2025-06-30 | Pyxis Oncology, Inc. | 0.96 | 59,046,716.00 | -37.34% | 44,339,556.00 | 2021-10-08 | 2750000 | 2500000 | 1 | tang | 127.27% | Increased |
| 114 | VYNE | 2025-06-30 | VYNE Therapeutics Inc. | 1.55 | 23,651,394.00 | -48.51% | 10,466,058.00 | 2018-01-25 | 2262048 | 1370938 | 1 | cormorant | 1846.83% | Increased |
| 115 | MGNX | 2025-06-30 | MacroGenics, Inc. | 1.26 | 79,493,776.00 | -58.00% | 52,340,363.00 | 2013-10-10 | 2204104 | 1821573 | 2 | ecor1-tang | 732.32% | Increased |
| 116 | OABI | 2025-06-30 | OmniAb, Inc. | 1.93 | 235,720,544.00 | -42.22% | 99,520,435.00 | 2021-09-30 | 1089428 | 626108 | 2 | adar1-tang | 46.94% | Increased |
| 117 | ESTA | 2025-06-30 | Establishment Labs Holdings Inc | 31.45 | 909,169,216.00 | -11.56% | 16,562,689.00 | 2018-07-19 | 1067750 | 25000 | 1 | adar1 | 212.50% | Increased |
| 118 | RXRX | 2025-06-30 | Recursion Pharmaceuticals, Inc. | 5.76 | 2,315,468,288.00 | -14.54% | 382,695,117.00 | 2021-04-16 | 1013634 | 200323 | 2 | adar1-casdin | 11.09% | Increased |
| 119 | BCAB | 2025-06-30 | BioAtla, Inc. | 0.30 | 17,678,014.00 | -39.34% | 42,296,447.00 | 2020-12-16 | 611654 | 1544582 | 2 | adar1-tang | 12.41% | Increased |
| 120 | SAVA | 2025-06-30 | Cassava Sciences, Inc. | 1.44 | 69,563,376.00 | -45.04% | 43,475,174.00 | 2000-07-14 | 434074 | 239820 | 1 | tang | 19.91% | Increased |
| 121 | PYPD | 2025-06-30 | PolyPid Ltd. | 2.74 | 27,923,066.00 | -15.69% | 4,590,187.00 | 2020-06-26 | 366944 | 103950 | 1 | adar1 | 29.81% | Increased |
| 122 | IBIO | 2025-06-30 | iBio, Inc. | 0.89 | 8,961,293.00 | -69.52% | 8,599,460.00 | 2008-08-19 | 326832 | 429819 | 2 | adar1-opaleye | 14.62% | Increased |
| 123 | MGX | 2025-06-30 | Metagenomi, Inc. | 1.48 | 55,327,580.00 | -49.14% | 23,310,838.00 | 2024-02-09 | 296000 | 200000 | 1 | tang | 48.17% | Increased |
| 124 | CLOV | 2025-06-30 | Clover Health Investments, Corp | 3.68 | 1,880,137,856.00 | -1.08% | 400,755,222.00 | 2020-06-12 | 134757 | 48300 | 1 | adar1 | 70.67% | Increased |
| 125 | STTK | 2025-06-30 | Shattuck Labs, Inc. | 0.95 | 45,499,448.00 | -20.18% | 24,176,183.00 | 2020-10-09 | 81514 | 102948 | 1 | adar1 | 0.78% | Increased |
------------------------------------------------------------ ------------------------------------------------------------ Increased Positions (when all funds shares were added together) Sorted by Increase in Share %
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | VYNE | 2025-06-30 | VYNE Therapeutics Inc. | 1.55 | 23,651,394.00 | -48.51% | 10,466,058.00 | 2018-01-25 | 2262048 | 1370938 | 1 | cormorant | 1846.83% |
| 1 | MGNX | 2025-06-30 | MacroGenics, Inc. | 1.26 | 79,493,776.00 | -58.00% | 52,340,363.00 | 2013-10-10 | 2204104 | 1821573 | 2 | ecor1-tang | 732.32% |
| 2 | BIIB | 2025-06-30 | Biogen Inc. | 118.61 | 17,361,539,072.00 | -15.87% | 146,001,681.00 | 1991-09-17 | 30154159 | 240100 | 3 | adar1-logos-tang | 507.85% |
| 3 | BHVN | 2025-06-30 | Biohaven Ltd. | 20.37 | 2,079,064,192.00 | -47.81% | 84,648,084.00 | 2022-09-23 | 12449832 | 882341 | 4 | adar1-cormorant-logos-tang | 411.08% |
| 4 | IDXX | 2025-06-30 | IDEXX Laboratories, Inc. | 411.49 | 33,346,738,176.00 | -3.71% | 80,436,876.00 | 1991-06-21 | 8581440 | 16000 | 1 | tang | 220.00% |
| 5 | ESTA | 2025-06-30 | Establishment Labs Holdings Inc | 31.45 | 909,169,216.00 | -11.56% | 16,562,689.00 | 2018-07-19 | 1067750 | 25000 | 1 | adar1 | 212.50% |
| 6 | CTMX | 2025-06-30 | CytomX Therapeutics, Inc. | 0.66 | 52,545,540.00 | -24.68% | 73,975,451.00 | 2015-10-08 | 81147458 | 35747779 | 6 | adar1-baker-perceptive-racapital-orbimed-tang | 175.12% |
| 7 | SVRA | 2025-06-30 | Savara, Inc. | 3.01 | 519,625,312.00 | 7.50% | 101,850,947.00 | 2017-04-28 | 8209528 | 3600670 | 1 | adar1 | 164.70% |
| 8 | CDTX | 2025-06-30 | Cidara Therapeutics, Inc. | 19.44 | 212,936,048.00 | -12.35% | 3,569,414.00 | 2015-04-15 | 235790935 | 4840709 | 6 | adar1-baker-bvf-deeptrack-logos-racapital | 137.48% |
| 9 | TVTX | 2025-06-30 | Travere Therapeutics, Inc. | 14.50 | 1,287,189,632.00 | -22.00% | 75,506,943.00 | 2012-11-08 | 39726930 | 2684252 | 3 | perceptive-racapital-tang | 133.41% |
| 10 | ALMS | 2025-06-30 | Alumis Inc. | 6.48 | 352,559,296.00 | -10.00% | 4,764,450.00 | 2024-06-28 | 25337712 | 8445904 | 6 | adar1-baker-cormorant-orbimed-opaleye-tang | 127.66% |
| 11 | PYXS | 2025-06-30 | Pyxis Oncology, Inc. | 0.96 | 59,046,716.00 | -37.34% | 44,339,556.00 | 2021-10-08 | 2750000 | 2500000 | 1 | tang | 127.27% |
| 12 | TRVI | 2025-06-30 | Trevi Therapeutics, Inc. | 6.47 | 625,533,824.00 | 62.97% | 73,666,058.00 | 2019-05-07 | 25043848 | 4578400 | 4 | adar1-logos-orbimed-opaleye | 95.68% |
| 13 | ARDX | 2025-06-30 | Ardelyx, Inc. | 4.82 | 1,147,684,096.00 | -1.93% | 231,291,344.00 | 2014-06-19 | 3587310 | 915130 | 1 | adar1 | 86.48% |
| 14 | ARVN | 2025-06-30 | Arvinas, Inc. | 8.60 | 591,438,400.00 | -53.69% | 53,685,383.00 | 2018-09-27 | 47858893 | 6502567 | 4 | adar1-logos-opaleye-tang | 76.60% |
| 15 | CLOV | 2025-06-30 | Clover Health Investments, Corp | 3.68 | 1,880,137,856.00 | -1.08% | 400,755,222.00 | 2020-06-12 | 134757 | 48300 | 1 | adar1 | 70.67% |
| 16 | KROS | 2025-06-30 | Keros Therapeutics, Inc. | 14.07 | 570,707,328.00 | 23.31% | 30,728,590.00 | 2020-04-08 | 131190209 | 9826982 | 4 | adar1-logos-orbimed-tang | 69.64% |
| 17 | UNH | 2025-06-30 | UnitedHealth Group Incorporated | 599.47 | 548,342,366,208.00 | 10.78% | 912,224,315.00 | 1984-10-17 | 105764335 | 339021 | 2 | orbimed-tang | 65.59% |
| 18 | ROIV | 2025-06-30 | Roivant Sciences Ltd. | 9.86 | 7,035,592,704.00 | -8.19% | 370,553,369.00 | 2020-12-08 | 133205337 | 11819462 | 4 | adar1-baker-perceptive-orbimed | 63.00% |
| 19 | ITOS | 2025-06-30 | iTeos Therapeutics, Inc. | 6.51 | 248,644,896.00 | -19.23% | 29,147,629.00 | 2020-07-24 | 151968792 | 15242607 | 4 | adar1-ecor1-orbimed-tang | 60.21% |
------------------------------------------------------------ ------------------------------------------------------------ Increased Positions (when all funds shares were added together) Sorted by the Highest Fund Number
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | GPCR | 2025-06-30 | Structure Therapeutics Inc. | 15.90 | 911,750,528.00 | -36.80% | 148,959,516.00 | 2023-02-03 | 294939787 | 14220819 | 8 | adar1-baker-bvf-casdin-deeptrack-logos-racapital-orbimed | 48.71% |
| 1 | AKRO | 2025-06-30 | Akero Therapeutics, Inc. | 37.63 | 2,996,104,192.00 | 46.99% | 66,438,220.00 | 2019-06-20 | 515860894 | 9667558 | 8 | adar1-avoro-baker-deeptrack-ecor1-logos-perceptive-orbimed | 50.05% |
| 2 | MRUS | 2025-06-30 | Merus N.V. | 43.05 | 2,974,691,328.00 | 8.34% | 55,639,246.00 | 2016-05-19 | 339344745 | 6451421 | 7 | adar1-avoro-baker-cormorant-deeptrack-perceptive-tang | 33.82% |
| 3 | RVMD | 2025-06-30 | Revolution Medicines, Inc. | 36.76 | 6,834,161,152.00 | -8.47% | 168,212,518.00 | 2020-02-13 | 709106095 | 19274425 | 7 | adar1-baker-bvf-casdin-logos-opaleye-tang | 4.22% |
| 4 | RNA | 2025-06-30 | Avidity Biosciences, Inc. | 26.66 | 3,204,851,968.00 | -13.55% | 92,698,110.00 | 2020-06-12 | 555331242 | 19553917 | 7 | avoro-casdin-cormorant-ecor1-logos-racapital-orbimed | 2.43% |
| 5 | ALMS | 2025-06-30 | Alumis Inc. | 6.48 | 352,559,296.00 | -10.00% | 4,764,450.00 | 2024-06-28 | 25337712 | 8445904 | 6 | adar1-baker-cormorant-orbimed-opaleye-tang | 127.66% |
| 6 | CTMX | 2025-06-30 | CytomX Therapeutics, Inc. | 0.66 | 52,545,540.00 | -24.68% | 73,975,451.00 | 2015-10-08 | 81147458 | 35747779 | 6 | adar1-baker-perceptive-racapital-orbimed-tang | 175.12% |
| 7 | INSM | 2025-06-30 | Insmed Incorporated | 72.65 | 13,209,223,168.00 | -5.34% | 166,410,802.00 | 2000-06-01 | 1093615731 | 10866611 | 6 | baker-cormorant-deeptrack-perceptive-orbimed-tang | 55.14% |
| 8 | XNCR | 2025-06-30 | Xencor, Inc. | 8.54 | 601,744,640.00 | -57.85% | 63,604,579.00 | 2013-12-03 | 89923148 | 11440604 | 6 | adar1-baker-bvf-deeptrack-ecor1-logos | 3.27% |
| 9 | CDTX | 2025-06-30 | Cidara Therapeutics, Inc. | 19.44 | 212,936,048.00 | -12.35% | 3,569,414.00 | 2015-04-15 | 235790935 | 4840709 | 6 | adar1-baker-bvf-deeptrack-logos-racapital | 137.48% |
| 10 | ELVN | 2025-06-30 | Enliven Therapeutics, Inc. | 16.51 | 809,062,656.00 | -25.19% | 26,934,302.00 | 2020-03-12 | 190035541 | 9473357 | 5 | baker-cormorant-logos-racapital-orbimed | 0.64% |
| 11 | IRON | 2025-06-30 | Disc Medicine, Inc. | 38.73 | 1,338,857,344.00 | -34.07% | 26,301,510.00 | 2020-08-12 | 223257858 | 4215594 | 5 | baker-logos-racapital-orbimed-opaleye | 13.98% |
| 12 | TECX | 2025-06-30 | Tectonic Therapeutic, Inc. | 16.16 | 301,589,216.00 | -57.28% | 9,868,448.00 | 2018-06-21 | 53444934 | 2689730 | 5 | adar1-baker-deeptrack-ecor1-tang | 0.41% |
| 13 | VRDN | 2025-06-30 | Viridian Therapeutics, Inc. | 12.02 | 979,449,728.00 | -32.36% | 76,929,941.00 | 2014-06-18 | 147990673 | 10585885 | 5 | adar1-baker-deeptrack-perceptive-tang | 18.78% |
| 14 | TSHA | 2025-06-30 | Taysha Gene Therapies, Inc. | 1.25 | 255,227,488.00 | -25.45% | 127,701,667.00 | 2020-09-24 | 122823333 | 53170274 | 5 | adar1-avoro-baker-racapital-tang | 47.93% |
| 15 | STOK | 2025-06-30 | Stoke Therapeutics, Inc. | 7.69 | 415,857,504.00 | -21.53% | 37,143,295.00 | 2019-06-19 | 67843535 | 5977404 | 5 | adar1-baker-cormorant-opaleye-tang | 4.54% |
| 16 | IMCR | 2025-06-30 | Immunocore Holdings plc | 26.59 | 1,312,099,456.00 | -11.46% | 37,260,699.00 | 2021-02-05 | 245628581 | 7827552 | 5 | baker-bvf-deeptrack-logos-tang | 38.55% |
| 17 | ASND | 2025-06-30 | Ascendis Pharma A/S | 165.05 | 9,923,581,952.00 | 25.93% | 59,372,631.00 | 2015-01-28 | 2806680359 | 16261184 | 5 | adar1-avoro-perceptive-racapital-orbimed | 4.90% |
| 18 | SYRE | 2025-06-30 | Spyre Therapeutics, Inc. | 12.22 | 736,340,544.00 | -43.29% | 46,620,133.00 | 2016-04-07 | 83969934 | 5609214 | 5 | adar1-baker-deeptrack-perceptive-tang | 22.01% |
| 19 | MLTX | 2025-06-30 | MoonLake Immunotherapeutics | 34.90 | 2,208,566,272.00 | -22.88% | 28,073,483.00 | 2020-10-20 | 1540124153 | 32629749 | 5 | adar1-avoro-bvf-cormorant-logos | 4.01% |
------------------------------------------------------------ ------------------------------------------------------------ Closed Positions (No longer in any in any of the funds) Sorted by Value
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | Position | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | AMGN | 2025-03-31 | Amgen Inc. | 277.29 | 149,085,257,728.00 | 0.90% | 535,673,909.00 | 1983-06-17 | 48986564 | 157235 | 2 | deeptrack-orbimed | Closed |
| 1 | XTNT | 2025-03-31 | Xtant Medical Holdings, Inc. | 0.41 | 56,600,676.00 | -18.60% | 37,064,381.00 | 2010-07-01 | 34363858 | 73114592 | 1 | orbimed | Closed |
| 2 | GILD | 2025-03-31 | Gilead Sciences, Inc. | 104.54 | 130,322,702,336.00 | 12.46% | 1,242,681,021.00 | 1992-01-22 | 22129875 | 197500 | 1 | orbimed | Closed |
| 3 | GKOS | 2025-03-31 | Glaukos Corporation | 90.07 | 5,095,025,664.00 | -40.69% | 54,680,371.00 | 2015-06-25 | 18724996 | 190256 | 1 | racapital | Closed |
| 4 | CBLL | 2025-03-31 | CeriBell, Inc. | 15.00 | 538,024,512.00 | -28.02% | 21,912,327.00 | 2024-10-11 | 18001345 | 937082 | 2 | racapital-orbimed | Closed |
| 5 | DXCM | 2025-03-31 | DexCom, Inc. | 66.14 | 25,933,957,120.00 | -17.16% | 387,927,198.00 | 2005-04-14 | 12155620 | 178000 | 1 | perceptive | Closed |
| 6 | KMTS | 2025-03-31 | Kestra Medical Technologies, Lt | 24.28 | 1,245,957,376.00 | 11.17% | 23,036,693.00 | 2025-03-06 | 11214000 | 450000 | 2 | perceptive-orbimed | Closed |
| 7 | GEHC | 2025-03-31 | GE HealthCare Technologies Inc. | 62.81 | 28,757,118,976.00 | -26.42% | 456,100,188.00 | 2022-12-15 | 8071000 | 100000 | 1 | casdin | Closed |
| 8 | ADPT | 2025-03-31 | Adaptive Biotechnologies Corpor | 7.33 | 1,089,106,048.00 | -1.61% | 96,477,395.00 | 2019-06-27 | 6917122 | 930972 | 1 | perceptive | Closed |
| 9 | HUMA | 2025-03-31 | Humacyte, Inc. | 1.53 | 237,332,080.00 | -65.15% | 121,986,988.00 | 2020-12-01 | 5647567 | 3312356 | 1 | racapital | Closed |
| 10 | BOLD | 2025-03-31 | Boundless Bio, Inc. | 1.22 | 27,206,000.00 | -45.78% | 14,189,913.00 | 2024-03-28 | 3292753 | 2180631 | 1 | racapital | Closed |
| 11 | TIL | 2025-03-31 | Instil Bio, Inc. | 15.03 | 98,084,128.00 | -20.98% | 2,670,001.00 | 2021-03-19 | 2449722 | 141113 | 2 | adar1-orbimed | Closed |
| 12 | MREO | 2025-03-31 | Mereo BioPharma Group plc | 1.95 | 310,050,016.00 | -41.62% | 486,079,784.00 | 2019-04-24 | 1995662 | 886961 | 2 | adar1-perceptive | Closed |
| 13 | CRDF | 2025-03-31 | Cardiff Oncology, Inc. | 2.85 | 189,594,256.00 | -19.03% | 59,796,027.00 | 2004-07-27 | 1801996 | 573884 | 1 | orbimed | Closed |
| 14 | CAPR | 2025-03-31 | Capricor Therapeutics, Inc. | 11.25 | 513,865,120.00 | -19.99% | 40,145,727.00 | 2007-02-13 | 750659 | 79100 | 1 | tang | Closed |
| 15 | SGMO | 2025-03-31 | Sangamo Therapeutics, Inc. | 0.71 | 158,555,376.00 | -37.56% | 218,822,617.00 | 2000-04-06 | 691869 | 1055000 | 1 | opaleye | Closed |
| 16 | LXRX | 2025-03-31 | Lexicon Pharmaceuticals, Inc. | 0.51 | 184,288,624.00 | -35.47% | 182,278,875.00 | 2000-04-07 | 530043 | 1150268 | 1 | tang | Closed |
| 17 | OTLK | 2025-03-31 | Outlook Therapeutics, Inc. | 1.45 | 47,299,292.00 | -36.82% | 20,356,522.00 | 2016-06-14 | 488000 | 400000 | 1 | tang | Closed |
| 18 | RVPH | 2025-03-31 | Reviva Pharmaceuticals Holdings | 0.68 | 31,535,412.00 | -64.68% | 40,746,018.00 | 2018-10-18 | 486752 | 510329 | 1 | tang | Closed |
| 19 | NBTX | 2025-03-31 | Nanobiotix S.A. | 3.33 | 157,952,464.00 | 14.90% | 25,528,397.00 | 2020-12-11 | 376090 | 105053 | 1 | perceptive | Closed |
| 20 | XLO | 2025-03-31 | Xilio Therapeutics, Inc. | 0.71 | 36,707,552.00 | -35.55% | 21,998,135.00 | 2021-10-22 | 28976 | 40000 | 1 | adar1 | Closed |
| 21 | RLYB | 2025-03-31 | Rallybio Corporation | 0.25 | 10,415,483.00 | -72.88% | 19,732,013.00 | 2021-07-29 | 8770 | 13400 | 1 | adar1 | Closed |
------------------------------------------------------------ ------------------------------------------------------------ Decreased Positions (when all funds shares were added together) Sorted by Value
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | Position | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | MDGL | 2025-06-30 | Madrigal Pharmaceuticals, Inc. | 301.66 | 6,660,712,960.00 | -1.77% | 11,356,312.00 | 2007-02-06 | 1203621071 | 3977072 | 5 | adar1-avoro-baker-ecor1-logos | -3.46% | Decreased |
| 1 | RYTM | 2025-06-30 | Rhythm Pharmaceuticals, Inc. | 61.74 | 3,903,431,424.00 | 7.34% | 46,955,630.00 | 2017-10-09 | 915183487 | 14483043 | 7 | adar1-baker-logos-perceptive-racapital-orbimed-opaleye | -5.30% | Decreased |
| 2 | ARGX | 2025-06-30 | argenx SE | 596.20 | 36,474,028,032.00 | -7.91% | 60,989,637.00 | 2017-05-18 | 784120923 | 1422519 | 4 | adar1-avoro-baker-orbimed | -9.95% | Decreased |
| 3 | UTHR | 2025-06-30 | United Therapeutics Corporation | 291.38 | 13,312,861,184.00 | -21.15% | 41,324,592.00 | 1999-06-17 | 705444250 | 2455000 | 2 | avoro-logos | -8.22% | Decreased |
| 4 | VRNA | 2025-06-30 | Verona Pharma plc | 65.46 | 8,622,652,416.00 | 21.92% | 493,924,450.00 | 2017-04-28 | 596788829 | 6309884 | 5 | adar1-baker-cormorant-ecor1-perceptive | -7.31% | Decreased |
| 5 | EWTX | 2025-06-30 | Edgewise Therapeutics, Inc. | 11.42 | 1,200,710,272.00 | -54.92% | 54,187,991.00 | 2021-03-26 | 558227811 | 42580306 | 8 | adar1-baker-cormorant-perceptive-racapital-orbimed-opaleye-tang | -0.63% | Decreased |
| 6 | PCVX | 2025-06-30 | Vaxcyte, Inc. | 30.65 | 3,946,555,136.00 | -65.24% | 119,134,116.00 | 2020-06-12 | 498375308 | 15329908 | 6 | adar1-baker-cormorant-deeptrack-racapital-tang | -2.82% | Decreased |
| 7 | ACLX | 2025-06-30 | Arcellx, Inc. | 59.15 | 3,249,937,664.00 | -12.19% | 32,601,579.00 | 2022-02-04 | 427716427 | 6495314 | 5 | adar1-baker-cormorant-perceptive-racapital | -7.57% | Decreased |
| 8 | JANX | 2025-06-30 | Janux Therapeutics, Inc. | 28.80 | 1,702,226,816.00 | -36.09% | 37,290,619.00 | 2021-06-11 | 390957914 | 16924585 | 8 | adar1-cormorant-ecor1-logos-perceptive-racapital-orbimed-tang | -7.73% | Decreased |
| 9 | ETNB | 2025-06-30 | 89bio, Inc. | 6.06 | 884,663,040.00 | -7.90% | 107,537,788.00 | 2019-11-11 | 363493840 | 37015666 | 4 | adar1-avoro-deeptrack-racapital | -4.75% | Decreased |
| 10 | SPRY | 2025-06-30 | ARS Pharmaceuticals, Inc. | 14.05 | 1,378,583,168.00 | 24.78% | 47,452,700.00 | 2020-12-04 | 353353549 | 20249487 | 3 | cormorant-racapital-orbimed | -2.41% | Decreased |
| 11 | IMVT | 2025-06-30 | Immunovant, Inc. | 15.15 | 2,573,393,920.00 | -35.78% | 62,221,667.00 | 2019-06-21 | 286493392 | 17905837 | 5 | adar1-baker-deeptrack-logos-perceptive | -5.99% | Decreased |
| 12 | IONS | 2025-06-30 | Ionis Pharmaceuticals, Inc. | 28.40 | 4,514,605,568.00 | -13.10% | 157,589,727.00 | 1991-05-17 | 280654938 | 7103390 | 4 | adar1-bvf-deeptrack-tang | -25.43% | Decreased |
| 13 | XENE | 2025-06-30 | Xenon Pharmaceuticals Inc. | 31.40 | 2,403,443,968.00 | -17.91% | 70,775,310.00 | 2014-11-05 | 266938262 | 8528379 | 6 | adar1-avoro-baker-deeptrack-perceptive-orbimed | -6.69% | Decreased |
| 14 | OCUL | 2025-06-30 | Ocular Therapeutix, Inc. | 7.31 | 1,162,450,816.00 | -9.64% | 124,121,633.00 | 2014-07-25 | 236541818 | 25489420 | 4 | avoro-deeptrack-logos-opaleye | -6.17% | Decreased |
| 15 | GH | 2025-06-30 | Guardant Health, Inc. | 44.97 | 5,550,242,304.00 | -0.35% | 111,589,027.00 | 2018-10-04 | 226374000 | 4350000 | 2 | casdin-deeptrack | -23.60% | Decreased |
| 16 | NAMS | 2025-06-30 | NewAmsterdam Pharma Company N.V | 15.12 | 1,660,448,128.00 | -38.49% | 53,941,411.00 | 2021-02-09 | 225040238 | 12426297 | 3 | adar1-cormorant-racapital | -4.58% | Decreased |
| 17 | SLNO | 2025-06-30 | Soleno Therapeutics, Inc. | 69.98 | 3,209,093,888.00 | 42.32% | 31,320,071.00 | 2014-11-13 | 213452086 | 2547769 | 4 | adar1-avoro-perceptive-tang | -41.44% | Decreased |
| 18 | ANAB | 2025-06-30 | AnaptysBio, Inc. | 20.55 | 630,202,688.00 | 21.74% | 18,032,374.00 | 2017-01-26 | 204483601 | 9210973 | 2 | ecor1-tang | -4.81% | Decreased |
| 19 | MIRM | 2025-06-30 | Mirum Pharmaceuticals, Inc. | 39.10 | 1,933,663,104.00 | -18.51% | 38,862,861.00 | 2019-07-18 | 203425650 | 3997360 | 2 | bvf-tang | -0.90% | Decreased |
| 20 | DVAX | 2025-06-30 | Dynavax Technologies Corporatio | 10.31 | 1,279,172,096.00 | -18.69% | 99,188,424.00 | 2004-02-19 | 197516981 | 19910986 | 3 | adar1-deeptrack-tang | -16.03% | Decreased |
| 21 | TARS | 2025-06-30 | Tarsus Pharmaceuticals, Inc. | 46.43 | 1,931,836,288.00 | -1.25% | 29,909,637.00 | 2020-10-16 | 190506255 | 4702697 | 4 | cormorant-deeptrack-orbimed-tang | -5.81% | Decreased |
| 22 | CRNX | 2025-06-30 | Crinetics Pharmaceuticals, Inc. | 30.42 | 2,830,535,168.00 | -21.52% | 91,642,575.00 | 2018-07-18 | 177456246 | 6170245 | 5 | adar1-baker-cormorant-ecor1-orbimed | -1.91% | Decreased |
| 23 | BLFS | 2025-06-30 | BioLife Solutions, Inc. | 21.91 | 1,041,785,408.00 | -20.27% | 36,395,390.00 | 1989-11-22 | 166012334 | 7707165 | 1 | casdin | -11.48% | Decreased |
| 24 | FOLD | 2025-06-30 | Amicus Therapeutics, Inc. | 6.83 | 2,098,449,152.00 | -28.18% | 250,897,044.00 | 2007-05-31 | 158710858 | 27698230 | 3 | avoro-perceptive-orbimed | -37.41% | Decreased |
| 25 | SEPN | 2025-06-30 | Septerna, Inc. | 5.72 | 254,211,088.00 | -66.35% | 19,629,806.00 | 2024-10-25 | 156460787 | 14802345 | 8 | adar1-avoro-bvf-casdin-deeptrack-logos-perceptive-racapital | -7.78% | Decreased |
| 26 | GERN | 2025-06-30 | Geron Corporation | 1.27 | 808,879,552.00 | -57.09% | 601,237,820.00 | 1996-07-31 | 146386964 | 103820542 | 3 | adar1-deeptrack-racapital | -2.81% | Decreased |
| 27 | DYN | 2025-06-30 | Dyne Therapeutics, Inc. | 7.04 | 796,371,840.00 | -53.96% | 97,275,317.00 | 2020-09-17 | 142002653 | 14916245 | 5 | adar1-logos-perceptive-racapital-orbimed | -8.74% | Decreased |
| 28 | GLPG | 2025-06-30 | Galapagos NV | 24.66 | 1,640,030,592.00 | 3.48% | 44,538,512.00 | 2012-02-27 | 140707298 | 5027056 | 2 | ecor1-tang | -20.36% | Decreased |
| 29 | ALNY | 2025-06-30 | Alnylam Pharmaceuticals, Inc. | 234.56 | 30,358,396,928.00 | -11.48% | 124,460,110.00 | 2004-06-01 | 138066506 | 423400 | 2 | casdin-orbimed | -9.16% | Decreased |
| 30 | NRIX | 2025-06-30 | Nurix Therapeutics, Inc. | 10.24 | 780,652,544.00 | -47.76% | 59,122,228.00 | 2020-07-24 | 126146756 | 11075220 | 4 | adar1-baker-deeptrack-perceptive | -0.66% | Decreased |
| 31 | NBIX | 2025-06-30 | Neurocrine Biosciences, Inc. | 101.38 | 10,030,354,432.00 | -30.50% | 98,515,061.00 | 1996-05-23 | 124884327 | 993590 | 4 | logos-perceptive-orbimed-tang | -16.13% | Decreased |
| 32 | NUVL | 2025-06-30 | Nuvalent, Inc. | 66.29 | 4,746,225,152.00 | -7.75% | 40,974,058.00 | 2021-07-29 | 120627172 | 1580959 | 4 | adar1-baker-perceptive-tang | -27.61% | Decreased |
| 33 | CNTA | 2025-06-30 | Centessa Pharmaceuticals plc | 11.57 | 1,540,938,880.00 | -24.18% | 93,006,626.00 | 2021-05-28 | 119315155 | 9080301 | 6 | adar1-avoro-cormorant-deeptrack-perceptive-tang | -16.27% | Decreased |
| 34 | HROW | 2025-06-30 | Harrow, Inc. | 24.09 | 858,909,696.00 | -30.66% | 26,130,229.00 | 2007-09-28 | 119258700 | 3905000 | 1 | opaleye | -1.26% | Decreased |
| 35 | BBIO | 2025-06-30 | BridgeBio Pharma, Inc. | 33.87 | 6,441,700,864.00 | -6.13% | 139,058,316.00 | 2019-06-27 | 119162076 | 2759659 | 3 | adar1-cormorant-deeptrack | -46.31% | Decreased |
| 36 | IDYA | 2025-06-30 | IDEAYA Biosciences, Inc. | 17.08 | 1,495,138,816.00 | -26.22% | 86,629,628.00 | 2019-05-23 | 114847563 | 5463728 | 2 | baker-logos | -7.54% | Decreased |
| 37 | ABCL | 2025-06-30 | AbCellera Biologics Inc. | 2.40 | 715,171,200.00 | -20.00% | 202,801,468.00 | 2020-12-11 | 114802813 | 33470208 | 3 | baker-orbimed-tang | -2.44% | Decreased |
| 38 | IMTX | 2025-06-30 | Immatics N.V. | 4.26 | 517,803,040.00 | -21.11% | 61,326,922.00 | 2018-12-12 | 109064747 | 20272258 | 3 | baker-perceptive-orbimed | -5.70% | Decreased |
| 39 | MBX | 2025-06-30 | MBX Biosciences, Inc. | 7.41 | 247,674,800.00 | -40.53% | 13,610,404.00 | 2024-09-13 | 98792722 | 8658433 | 6 | cormorant-deeptrack-ecor1-racapital-orbimed-opaleye | -19.40% | Decreased |
| 40 | BCAX | 2025-06-30 | Bicara Therapeutics Inc. | 10.77 | 587,215,936.00 | -17.09% | 28,372,303.00 | 2024-09-13 | 91093328 | 9805525 | 4 | adar1-deeptrack-logos-racapital | -2.80% | Decreased |
| 41 | CGON | 2025-06-30 | CG Oncology, Inc. | 19.28 | 1,469,461,760.00 | -32.78% | 60,853,824.00 | 2024-01-25 | 87868716 | 3379566 | 5 | adar1-cormorant-orbimed-opaleye-tang | -8.96% | Decreased |
| 42 | SLDB | 2025-06-30 | Solid Biosciences Inc. | 2.55 | 197,607,152.00 | -21.78% | 39,269,557.00 | 2018-01-26 | 86286509 | 17717969 | 2 | perceptive-racapital | -0.97% | Decreased |
| 43 | BCYC | 2025-06-30 | Bicycle Therapeutics plc | 7.39 | 511,405,728.00 | -45.50% | NaN | 2019-05-23 | 84015777 | 12088601 | 2 | baker-deeptrack | -11.48% | Decreased |
| 44 | GRAL | 2025-06-30 | GRAIL, Inc. | 23.26 | 788,402,368.00 | 25.26% | 22,501,359.00 | 2024-06-12 | 83821028 | 1630125 | 1 | baker | -0.69% | Decreased |
| 45 | UPB | 2025-06-30 | Upstream Bio, Inc. | 7.37 | 395,333,440.00 | -35.52% | 31,148,731.00 | 2024-10-11 | 78357189 | 7136356 | 2 | deeptrack-orbimed | -11.55% | Decreased |
| 46 | EYPT | 2025-06-30 | EyePoint Pharmaceuticals, Inc. | 5.67 | 390,035,968.00 | -25.62% | 43,542,419.00 | 2005-01-27 | 78338250 | 8325000 | 1 | cormorant | -36.18% | Decreased |
| 47 | CMPX | 2025-06-30 | Compass Therapeutics, Inc. | 1.70 | 234,388,000.00 | -13.08% | 83,586,239.00 | 2021-04-05 | 74727125 | 28741202 | 3 | adar1-orbimed-tang | -15.37% | Decreased |
| 48 | XOMA | 2025-06-30 | XOMA Royalty Corporation | 19.97 | 239,214,624.00 | -21.38% | 8,907,733.00 | 1986-06-06 | 71703828 | 2845390 | 2 | bvf-opaleye | -12.07% | Decreased |
| 49 | IMNM | 2025-06-30 | Immunome, Inc. | 7.10 | 617,350,016.00 | -29.28% | 69,554,437.00 | 2020-10-02 | 70763663 | 7608996 | 2 | ecor1-opaleye | -0.53% | Decreased |
| 50 | FULC | 2025-06-30 | Fulcrum Therapeutics, Inc. | 3.29 | 177,591,888.00 | -17.75% | 26,503,299.00 | 2019-07-18 | 70743242 | 10282448 | 2 | adar1-racapital | -4.08% | Decreased |
| 51 | KURA | 2025-06-30 | Kura Oncology, Inc. | 5.90 | 476,587,840.00 | -20.16% | 59,769,977.00 | 2015-09-16 | 69750235 | 12088429 | 4 | adar1-bvf-ecor1-tang | -16.77% | Decreased |
| 52 | EOLS | 2025-06-30 | Evolus, Inc. Common Stock | 10.79 | 686,101,568.00 | -19.96% | 56,934,307.00 | 2018-02-08 | 68819349 | 7472242 | 2 | perceptive-tang | -18.13% | Decreased |
| 53 | CRSP | 2025-06-30 | CRISPR Therapeutics AG | 37.77 | 3,261,938,176.00 | -9.01% | 85,368,761.00 | 2016-10-19 | 67574385 | 1389276 | 1 | ecor1 | -39.85% | Decreased |
| 54 | CGEM | 2025-06-30 | Cullinan Therapeutics, Inc. | 7.71 | 451,133,696.00 | -30.16% | 38,980,660.00 | 2021-01-08 | 66231440 | 8795676 | 3 | bvf-orbimed-tang | -0.90% | Decreased |
| 55 | DNLI | 2025-06-30 | Denali Therapeutics Inc. | 12.74 | 1,850,039,168.00 | -44.70% | 131,342,965.00 | 2017-12-08 | 65157180 | 4657411 | 3 | adar1-baker-casdin | -1.65% | Decreased |
| 56 | GLUE | 2025-06-30 | Monte Rosa Therapeutics, Inc. | 4.22 | 259,571,344.00 | -25.44% | 33,917,745.00 | 2021-06-24 | 64886456 | 14387241 | 4 | avoro-baker-bvf-casdin | -6.01% | Decreased |
| 57 | AMLX | 2025-06-30 | Amylyx Pharmaceuticals, Inc. | 3.65 | 323,399,104.00 | 14.78% | 58,959,626.00 | 2022-01-07 | 61027469 | 9520666 | 4 | adar1-perceptive-orbimed-tang | -2.79% | Decreased |
| 58 | APGE | 2025-06-30 | Apogee Therapeutics, Inc. | 31.80 | 1,847,179,264.00 | -22.27% | 39,041,674.00 | 2023-07-14 | 60811468 | 1400218 | 3 | adar1-perceptive-tang | -53.28% | Decreased |
| 59 | KALV | 2025-06-30 | KalVista Pharmaceuticals, Inc. | 12.00 | 596,587,200.00 | 37.14% | 29,072,212.00 | 2015-04-09 | 55980076 | 4951798 | 2 | adar1-tang | -0.52% | Decreased |
| 60 | NGNE | 2025-06-30 | Neurogene Inc. | 11.00 | 164,225,600.00 | -41.52% | 5,545,438.00 | 2014-03-07 | 53640884 | 3588019 | 4 | adar1-baker-casdin-ecor1 | -14.52% | Decreased |
| 61 | ITGR | 2025-06-30 | Integer Holdings Corporation | 116.50 | 4,064,673,280.00 | -13.80% | 32,987,365.00 | 2000-09-29 | 53295198 | 433400 | 1 | orbimed | -34.58% | Decreased |
| 62 | SIBN | 2025-06-30 | SI-BONE, Inc. | 13.85 | 587,975,424.00 | -19.90% | 37,756,528.00 | 2018-10-17 | 48536385 | 2578979 | 1 | orbimed | -25.09% | Decreased |
| 63 | RXST | 2025-06-30 | RxSight, Inc. | 14.08 | 570,106,240.00 | -54.17% | 32,215,490.00 | 2021-07-30 | 48138571 | 3702967 | 1 | racapital | -1.07% | Decreased |
| 64 | BCRX | 2025-06-30 | BioCryst Pharmaceuticals, Inc. | 7.40 | 1,546,304,000.00 | -2.76% | 195,072,537.00 | 1994-03-04 | 47488000 | 5300000 | 2 | avoro-tang | -44.27% | Decreased |
| 65 | ADMA | 2025-06-30 | ADMA Biologics Inc | 21.31 | 5,083,798,528.00 | 31.87% | 232,872,303.00 | 2013-10-17 | 42856652 | 2353468 | 2 | perceptive-tang | -2.88% | Decreased |
| 66 | SRRK | 2025-06-30 | Scholar Rock Holding Corporatio | 30.75 | 2,916,951,040.00 | -31.48% | 69,786,242.00 | 2018-05-25 | 41658524 | 1176130 | 2 | adar1-racapital | -18.63% | Decreased |
| 67 | SRPT | 2025-06-30 | Sarepta Therapeutics, Inc. | 53.79 | 5,219,356,672.00 | -53.94% | 92,551,132.00 | 1997-06-04 | 40706721 | 2380510 | 5 | adar1-casdin-deeptrack-opaleye-tang | -59.59% | Decreased |
| 68 | ATXS | 2025-06-30 | Astria Therapeutics, Inc. | 4.04 | 227,994,160.00 | -45.84% | 33,969,449.00 | 2015-06-25 | 40387954 | 7535066 | 4 | adar1-logos-perceptive-tang | -41.28% | Decreased |
| 69 | DRUG | 2025-06-30 | Bright Minds Biosciences Inc. | 28.83 | 203,078,224.00 | -18.58% | 2,524,284.00 | 2021-03-22 | 38643348 | 1480021 | 2 | cormorant-perceptive | -13.47% | Decreased |
| 70 | AUTL | 2025-06-30 | Autolus Therapeutics plc | 1.43 | 380,564,448.00 | -34.70% | 138,094,286.00 | 2018-06-22 | 38422895 | 16852147 | 1 | deeptrack | -39.29% | Decreased |
| 71 | ZLAB | 2025-06-30 | Zai Lab Limited | 29.54 | 3,238,676,992.00 | 17.18% | 983,033,752.00 | 2017-09-20 | 37817852 | 1081437 | 2 | adar1-orbimed | -51.63% | Decreased |
| 72 | EXAS | 2025-06-30 | Exact Sciences Corporation | 41.58 | 7,723,693,568.00 | -23.37% | 184,254,502.00 | 2001-02-01 | 37055372 | 697316 | 2 | casdin-orbimed | -36.02% | Decreased |
| 73 | NKTX | 2025-06-30 | Nkarta, Inc. | 1.81 | 128,433,248.00 | -25.82% | 48,884,788.00 | 2020-07-10 | 29648770 | 17860705 | 2 | racapital-tang | -4.40% | Decreased |
| 74 | CRGX | 2025-06-30 | CARGO Therapeutics, Inc. | 4.26 | 196,183,232.00 | -64.60% | 27,397,475.00 | 2023-11-13 | 29282529 | 7107410 | 3 | cormorant-opaleye-tang | -28.06% | Decreased |
| 75 | NPCE | 2025-06-30 | Neuropace, Inc. | 10.42 | 339,276,256.00 | -13.96% | 21,126,966.00 | 2021-04-22 | 29122010 | 2614184 | 1 | orbimed | -23.26% | Decreased |
| 76 | CMPS | 2025-06-30 | COMPASS Pathways Plc – American | 2.85 | 264,118,336.00 | -15.43% | 71,549,218.00 | 2020-09-18 | 28366820 | 10131007 | 2 | deeptrack-tang | -17.36% | Decreased |
| 77 | BEAM | 2025-06-30 | Beam Therapeutics Inc. | 17.00 | 1,697,280,000.00 | -30.70% | 73,199,019.00 | 2020-02-06 | 28151550 | 1655000 | 2 | casdin-tang | -28.60% | Decreased |
| 78 | ENGN | 2025-06-30 | enGene Holdings Inc. | 4.00 | 203,910,400.00 | -50.37% | 24,461,582.00 | 2022-02-01 | 27616440 | 7586934 | 4 | adar1-cormorant-deeptrack-orbimed | -2.69% | Decreased |
| 79 | BIOA | 2025-06-30 | BioAge Labs, Inc. | 3.68 | 131,928,000.00 | -21.70% | 23,819,840.00 | 2024-09-26 | 27256708 | 6599687 | 4 | adar1-cormorant-orbimed-tang | -8.02% | Decreased |
| 80 | ORIC | 2025-06-30 | Oric Pharmaceuticals, Inc. | 4.77 | 338,797,824.00 | -52.30% | 46,231,360.00 | 2020-04-24 | 25551092 | 2517349 | 2 | ecor1-orbimed | -38.87% | Decreased |
| 81 | ANNX | 2025-06-30 | Annexon, Inc. | 1.46 | 160,176,608.00 | -64.99% | 81,750,277.00 | 2020-07-24 | 22584000 | 9410000 | 2 | bvf-logos | -14.45% | Decreased |
| 82 | MNKD | 2025-06-30 | MannKind Corporation | 4.54 | 1,379,506,176.00 | -24.83% | 298,491,009.00 | 2004-07-28 | 21879000 | 5850000 | 1 | avoro | -33.14% | Decreased |
| 83 | VKTX | 2025-06-30 | Viking Therapeutics, Inc. | 24.99 | 2,881,321,984.00 | -25.31% | 109,861,197.00 | 2015-04-28 | 21690594 | 818513 | 3 | adar1-perceptive-tang | -2.37% | Decreased |
| 84 | IKT | 2025-06-30 | Inhibikase Therapeutics, Inc. | 2.07 | 153,886,912.00 | -22.18% | 25,709,535.00 | 2020-12-23 | 20581076 | 10554398 | 2 | adar1-perceptive | -4.46% | Decreased |
| 85 | PRTA | 2025-06-30 | Prothena Corporation plc | 9.20 | 495,208,384.00 | -34.80% | 32,018,442.00 | 2012-12-18 | 20486305 | 3375009 | 1 | adar1 | -70.87% | Decreased |
| 86 | URGN | 2025-06-30 | UroGen Pharma Ltd. | 9.87 | 466,014,016.00 | -5.82% | 36,992,561.00 | 2017-05-04 | 20391080 | 1488400 | 3 | adar1-orbimed-tang | -53.58% | Decreased |
| 87 | VSTM | 2025-06-30 | Verastem, Inc. | 7.50 | 386,175,008.00 | 31.81% | 38,014,694.00 | 2012-01-27 | 19398864 | 4674425 | 3 | bvf-logos-tang | -19.86% | Decreased |
| 88 | PODD | 2025-06-30 | Insulet Corporation | 253.99 | 17,836,726,272.00 | -5.22% | 69,910,789.00 | 2007-05-15 | 18972388 | 60387 | 1 | perceptive | -15.66% | Decreased |
| 89 | TMO | 2025-06-30 | Thermo Fisher Scientific Inc | 438.15 | 165,398,118,400.00 | -21.13% | 376,446,298.00 | 1980-03-17 | 18853890 | 46500 | 1 | orbimed | -63.95% | Decreased |
| 90 | AVTX | 2025-06-30 | Avalo Therapeutics, Inc. | 4.90 | 52,292,312.00 | -28.68% | 3,682,884.00 | 2015-10-14 | 18660215 | 3739522 | 6 | adar1-bvf-deeptrack-perceptive-racapital-orbimed | -14.24% | Decreased |
| 91 | CERS | 2025-06-30 | Cerus Corporation | 1.30 | 241,526,992.00 | -29.73% | 158,448,986.00 | 1997-01-31 | 18166220 | 12883844 | 1 | baker | -33.42% | Decreased |
| 92 | ALDX | 2025-06-30 | Aldeyra Therapeutics, Inc. | 2.19 | 130,762,056.00 | -55.21% | 47,818,870.00 | 2014-05-02 | 16474941 | 4301551 | 2 | adar1-perceptive | -54.66% | Decreased |
| 93 | VIR | 2025-06-30 | Vir Biotechnology, Inc. | 6.12 | 868,421,888.00 | -40.47% | 92,043,716.00 | 2019-10-11 | 15993201 | 3173254 | 3 | adar1-baker-orbimed | -10.38% | Decreased |
| 94 | ADCT | 2025-06-30 | ADC Therapeutics SA | 1.21 | 119,891,400.00 | -31.25% | 73,042,624.00 | 2020-05-18 | 15831701 | 5907351 | 1 | orbimed | -1.02% | Decreased |
| 95 | SERA | 2025-06-30 | Sera Prognostics, Inc. | 3.25 | 122,406,704.00 | -48.66% | 24,854,185.00 | 2021-07-15 | 15229931 | 5498170 | 1 | baker | -35.55% | Decreased |
| 96 | ARQT | 2025-06-30 | Arcutis Biotherapeutics, Inc. | 13.01 | 1,543,480,448.00 | -0.54% | 85,242,758.00 | 2020-01-31 | 14020000 | 1000000 | 1 | cormorant | -25.93% | Decreased |
| 97 | INBX | 2025-06-30 | Inhibrx Biosciences, Inc. | 11.47 | 166,038,576.00 | -19.17% | 7,712,906.00 | 2024-06-04 | 13954518 | 977892 | 1 | perceptive | -8.10% | Decreased |
| 98 | TARA | 2025-06-30 | Protara Therapeutics, Inc. | 3.90 | 143,393,248.00 | -18.07% | 30,107,039.00 | 2014-10-22 | 12517216 | 2553817 | 4 | adar1-baker-racapital-opaleye | -55.89% | Decreased |
| 99 | TCRX | 2025-06-30 | TScan Therapeutics, Inc. | 1.24 | 70,172,344.00 | -54.41% | 37,137,033.00 | 2021-07-16 | 12485755 | 8610866 | 3 | baker-bvf-tang | -3.65% | Decreased |
| 100 | TDOC | 2025-06-30 | Teladoc Health, Inc. | 7.25 | 1,270,765,440.00 | -25.26% | 159,717,484.00 | 2015-06-30 | 12194000 | 1400000 | 1 | tang | -17.65% | Decreased |
| 101 | PEPG | 2025-06-30 | PepGen Inc. | 1.13 | 36,942,412.00 | -59.64% | 10,471,699.00 | 2022-05-06 | 12154386 | 10949897 | 3 | adar1-racapital-opaleye | -1.62% | Decreased |
| 102 | PLRX | 2025-06-30 | Pliant Therapeutics, Inc. | 1.46 | 89,405,000.00 | -86.81% | 50,199,674.00 | 2020-06-03 | 11634795 | 10029996 | 3 | adar1-deeptrack-tang | -30.35% | Decreased |
| 103 | KRRO | 2025-06-30 | Korro Bio, Inc. | 12.90 | 121,116,808.00 | -66.19% | 4,913,494.00 | 2019-10-03 | 10543820 | 844181 | 4 | adar1-cormorant-deeptrack-orbimed | -37.75% | Decreased |
| 104 | AZN | 2025-06-30 | Astrazeneca PLC | 67.59 | 209,553,309,696.00 | -0.54% | 1,544,514,614.00 | 1993-05-12 | 10482000 | 150000 | 1 | tang | -40.00% | Decreased |
| 105 | SNY | 2025-06-30 | Sanofi | 50.90 | 126,228,955,136.00 | -1.53% | 1,129,611,427.00 | 2002-07-01 | 10145100 | 210000 | 2 | adar1-tang | -22.22% | Decreased |
| 106 | NVAX | 2025-06-30 | Novavax, Inc. | 6.00 | 965,064,000.00 | -31.90% | 135,577,182.00 | 1995-12-05 | 10070815 | 1598542 | 2 | deeptrack-tang | -24.53% | Decreased |
| 107 | ACRV | 2025-06-30 | Acrivon Therapeutics, Inc. | 1.62 | 50,789,432.00 | -70.60% | 11,274,619.00 | 2022-11-15 | 9952348 | 8363317 | 2 | baker-racapital | -39.06% | Decreased |
| 108 | KALA | 2025-06-30 | KALA BIO, Inc. | 3.46 | 22,293,042.00 | -55.01% | 3,851,888.00 | 2017-07-20 | 9567496 | 2009978 | 4 | adar1-baker-cormorant-perceptive | -15.60% | Decreased |
| 109 | AVR | 2025-06-30 | Anteris Technologies Global Cor | 2.47 | 88,771,304.00 | -55.89% | 27,873,412.00 | 2024-12-13 | 8476885 | 2236645 | 2 | adar1-perceptive | -41.42% | Decreased |
| 110 | MRNA | 2025-06-30 | Moderna, Inc. | 24.71 | 9,555,387,392.00 | -31.14% | 359,997,079.00 | 2018-12-07 | 8423227 | 305300 | 1 | tang | -42.43% | Decreased |
| 111 | AQST | 2025-06-30 | Aquestive Therapeutics, Inc. | 2.51 | 248,167,216.00 | -21.81% | 94,253,087.00 | 2018-07-25 | 7250290 | 2190420 | 1 | perceptive | -41.23% | Decreased |
| 112 | VTYX | 2025-06-30 | Ventyx Biosciences, Inc. | 0.97 | 68,889,496.00 | -50.33% | 54,957,214.00 | 2021-10-21 | 6994804 | 3268600 | 2 | adar1-tang | -8.48% | Decreased |
| 113 | IVVD | 2025-06-30 | Invivyd, Inc. | 0.55 | 65,858,592.00 | 37.59% | 47,996,574.00 | 2021-08-06 | 6424976 | 8985980 | 2 | deeptrack-tang | -18.72% | Decreased |
| 114 | DNA | 2025-06-30 | Ginkgo Bioworks Holdings, Inc. | 8.12 | 471,232,832.00 | -8.35% | 36,712,127.00 | 2021-04-19 | 6035546 | 536493 | 2 | casdin-opaleye | -80.08% | Decreased |
| 115 | TEVA | 2025-06-30 | Teva Pharmaceutical Industries | 13.65 | 15,656,003,584.00 | -37.44% | 1,128,838,460.00 | 1982-02-16 | 5796915 | 345878 | 1 | adar1 | -84.45% | Decreased |
| 116 | DAWN | 2025-06-30 | Day One Biopharmaceuticals, Inc | 7.12 | 721,647,616.00 | -38.41% | 71,972,855.00 | 2021-05-27 | 5785592 | 890091 | 2 | adar1-ecor1 | -86.61% | Decreased |
| 117 | TXG | 2025-06-30 | 10x Genomics, Inc. | 8.30 | 1,023,240,640.00 | -44.11% | 106,469,868.00 | 2019-09-12 | 5504472 | 475343 | 1 | racapital | -75.55% | Decreased |
| 118 | SRZN | 2025-06-30 | Surrozen, Inc. | 9.00 | 76,451,216.00 | -20.49% | 2,128,396.00 | 2021-01-11 | 5387476 | 602626 | 1 | racapital | -11.27% | Decreased |
| 119 | IMUX | 2025-06-30 | Immunic, Inc. | 0.98 | 93,901,152.00 | 3.16% | 64,834,702.00 | 2014-04-17 | 5337948 | 7652972 | 1 | bvf | -14.04% | Decreased |
| 120 | CTNM | 2025-06-30 | Contineum Therapeutics, Inc. | 4.01 | 103,745,120.00 | -69.69% | 13,299,011.00 | 2024-04-05 | 5268658 | 1327118 | 4 | adar1-baker-casdin-perceptive | -35.91% | Decreased |
| 121 | FATE | 2025-06-30 | Fate Therapeutics, Inc. | 1.11 | 127,202,672.00 | -15.91% | 99,964,480.00 | 2013-10-01 | 4875126 | 4352791 | 2 | baker-tang | -36.05% | Decreased |
| 122 | ALGS | 2025-06-30 | Aligos Therapeutics, Inc. | 4.08 | 24,946,384.00 | -88.12% | 4,373,872.00 | 2020-10-16 | 4818415 | 668296 | 3 | baker-deeptrack-tang | -11.70% | Decreased |
| 123 | GOSS | 2025-06-30 | Gossamer Bio, Inc. | 0.84 | 191,433,680.00 | -8.62% | 183,672,034.00 | 2019-02-08 | 4639840 | 3772228 | 2 | adar1-opaleye | -16.44% | Decreased |
| 124 | ATRA | 2025-06-30 | Atara Biotherapeutics, Inc. | 6.17 | 36,149,476.00 | 1.98% | 4,197,850.00 | 2014-10-16 | 4424973 | 573183 | 1 | ecor1 | -11.60% | Decreased |
| 125 | HRTX | 2025-06-30 | Heron Therapeutics, Inc. | 1.84 | 280,287,200.00 | 12.88% | 115,963,945.00 | 1987-08-26 | 4420400 | 2135459 | 1 | tang | -4.47% | Decreased |
| 126 | RCKT | 2025-06-30 | Rocket Pharmaceuticals, Inc. | 6.33 | 674,967,872.00 | -37.70% | 80,783,728.00 | 2015-02-18 | 4110804 | 1677879 | 3 | adar1-baker-tang | -27.98% | Decreased |
| 127 | INO | 2025-06-30 | Inovio Pharmaceuticals, Inc. | 1.74 | 63,811,892.00 | -20.91% | 33,103,900.00 | 1998-12-08 | 4032088 | 1981370 | 1 | deeptrack | -36.48% | Decreased |
| 128 | PRME | 2025-06-30 | Prime Medicine, Inc. | 1.33 | 174,444,128.00 | -51.99% | 60,638,823.00 | 2022-10-20 | 3870922 | 1567175 | 1 | casdin | -25.22% | Decreased |
| 129 | IOVA | 2025-06-30 | Iovance Biotherapeutics, Inc. | 3.06 | 1,003,303,552.00 | -47.96% | 251,861,761.00 | 2010-10-15 | 3096000 | 1800000 | 1 | tang | -87.61% | Decreased |
| 130 | ZURA | 2025-06-30 | Zura Bio Limited | 1.21 | 82,733,752.00 | -39.20% | 46,618,074.00 | 2023-03-21 | 2861364 | 2725109 | 2 | adar1-deeptrack | -70.71% | Decreased |
| 131 | DTIL | 2025-06-30 | Precision BioSciences, Inc. | 5.02 | 52,961,500.00 | 10.09% | 8,756,605.00 | 2019-03-28 | 2745326 | 653649 | 1 | tang | -2.92% | Decreased |
| 132 | ACRS | 2025-06-30 | Aclaris Therapeutics, Inc. | 1.14 | 123,288,720.00 | -56.15% | 66,068,981.00 | 2015-10-06 | 2627000 | 1850000 | 1 | logos | -73.15% | Decreased |
| 133 | ALEC | 2025-06-30 | Alector, Inc. | 0.92 | 91,168,936.00 | -46.82% | 73,332,475.00 | 2019-02-07 | 2412936 | 1723526 | 1 | adar1 | -82.89% | Decreased |
| 134 | PFE | 2025-06-30 | Pfizer, Inc. | 22.14 | 125,565,902,848.00 | -16.89% | 5,657,705,935.00 | 1972-06-01 | 2240733 | 92439 | 2 | adar1-tang | -97.66% | Decreased |
| 135 | RCEL | 2025-06-30 | Avita Medical, Inc. | 8.62 | 227,201,648.00 | -2.27% | 25,848,578.00 | 2012-05-14 | 2060556 | 389519 | 1 | opaleye | -11.47% | Decreased |
| 136 | DCTH | 2025-06-30 | Delcath Systems, Inc. | 10.66 | 356,391,520.00 | -16.65% | 31,032,851.00 | 2018-05-03 | 2031636 | 149385 | 1 | adar1 | -75.58% | Decreased |
| 137 | ACHC | 2025-06-30 | Acadia Healthcare Company, Inc. | 26.15 | 2,409,142,016.00 | -42.41% | 90,430,406.00 | 1994-03-04 | 2025355 | 89262 | 1 | racapital | -58.87% | Decreased |
| 138 | STRO | 2025-06-30 | Sutro Biopharma, Inc. | 0.53 | 43,948,524.00 | -73.64% | 70,805,238.00 | 2018-09-27 | 1828716 | 2561586 | 1 | tang | -44.73% | Decreased |
| 139 | CADL | 2025-06-30 | Candel Therapeutics, Inc. | 4.97 | 234,760,432.00 | -36.04% | 35,925,874.00 | 2021-07-27 | 1796867 | 355112 | 1 | baker | -85.43% | Decreased |
| 140 | NMRA | 2025-06-30 | Neumora Therapeutics, Inc. | 0.68 | 110,437,288.00 | -71.83% | 85,270,564.00 | 2023-09-14 | 1785292 | 2434600 | 2 | baker-tang | -1.06% | Decreased |
| 141 | RGNX | 2025-06-30 | REGENXBIO Inc. | 5.94 | 297,694,400.00 | -21.53% | 41,056,108.00 | 2015-09-17 | 1706186 | 207818 | 1 | adar1 | -40.68% | Decreased |
| 142 | JNJ | 2025-06-30 | Johnson & Johnson | 157.47 | 379,479,097,344.00 | 6.29% | 2,403,933,039.00 | 1962-01-02 | 1446778 | 9472 | 1 | tang | -22.63% | Decreased |
| 143 | IPSC | 2025-06-30 | Century Therapeutics, Inc. | 0.48 | 41,301,600.00 | -50.52% | 39,812,176.00 | 2021-06-18 | 1189020 | 2128190 | 2 | casdin-tang | -51.12% | Decreased |
| 144 | VTRS | 2025-06-30 | Viatris Inc. | 7.54 | 9,000,422,400.00 | -36.10% | 1,185,535,855.00 | 1980-03-17 | 1146241 | 128359 | 1 | tang | -24.04% | Decreased |
| 145 | LXEO | 2025-06-30 | Lexeo Therapeutics, Inc. | 1.98 | 65,730,060.00 | -68.77% | 21,795,488.00 | 2023-11-03 | 1145475 | 284944 | 2 | adar1-perceptive | -66.74% | Decreased |
| 146 | CMMB | 2025-06-30 | Chemomab Therapeutics Ltd. | 1.07 | 20,114,334.00 | -46.13% | 236,378,933.00 | 2019-02-12 | 1091548 | 940990 | 1 | orbimed | -45.96% | Decreased |
| 147 | TRAW | 2025-06-30 | Traws Pharma, Inc. | 2.00 | 10,066,580.00 | -72.71% | 4,277,814.00 | 2013-07-25 | 896186 | 605531 | 1 | orbimed | -41.06% | Decreased |
| 148 | APLT | 2025-06-30 | Applied Therapeutics, Inc. | 0.33 | 47,144,808.00 | -49.16% | 103,058,488.00 | 2019-05-14 | 755403 | 2428169 | 1 | tang | -26.15% | Decreased |
| 149 | BDSX | 2025-06-30 | Biodesix, Inc. | 0.53 | 77,368,336.00 | -57.26% | 66,204,129.00 | 2020-10-28 | 613034 | 2173880 | 1 | perceptive | -59.73% | Decreased |
| 150 | PHAT | 2025-06-30 | Phathom Pharmaceuticals, Inc. | 4.03 | 280,637,120.00 | -40.65% | 56,653,838.00 | 2019-10-25 | 608236 | 63424 | 1 | adar1 | -94.90% | Decreased |
| 151 | KPRX | 2025-06-30 | Kiora Pharmaceuticals, Inc. | 2.66 | 7,982,101.00 | -21.99% | 1,762,573.00 | 2015-02-13 | 481280 | 167111 | 1 | adar1 | -14.15% | Decreased |
| 152 | SPRO | 2025-06-30 | Spero Therapeutics, Inc. | 0.75 | 42,160,232.00 | -15.83% | 41,896,412.00 | 2017-11-02 | 417359 | 143917 | 1 | adar1 | -82.04% | Decreased |
| 153 | TXMD | 2025-06-30 | TherapeuticsMD, Inc. | 1.15 | 13,310,560.00 | -0.86% | 9,513,315.00 | 2007-05-09 | 242684 | 209210 | 1 | adar1 | -22.56% | Decreased |
| 154 | QNCX | 2025-06-30 | Quince Therapeutics, Inc. | 1.00 | 44,001,600.00 | -42.20% | 32,660,220.00 | 2019-05-09 | 235881 | 142958 | 1 | adar1 | -56.33% | Decreased |
| 155 | TNYA | 2025-06-30 | Tenaya Therapeutics, Inc. | 0.49 | 80,137,168.00 | -67.14% | 55,205,093.00 | 2021-07-30 | 221235 | 361969 | 1 | casdin | -94.62% | Decreased |
| 156 | PHGE | 2025-06-30 | BiomX Inc. | 0.54 | 13,474,203.00 | -29.36% | 17,770,088.00 | 2019-03-13 | 134819 | 299598 | 1 | adar1 | -85.65% | Decreased |
| 157 | LSB | 2025-06-30 | LakeShore Biopharma Co., Ltd | 1.69 | 32,246,554.00 | -40.93% | 3,598,630.00 | 2021-08-05 | 55895 | 54799 | 1 | orbimed | -60.98% | Decreased |
| 158 | CASI | 2025-06-30 | CASI Pharmaceuticals, Inc. | 1.94 | 30,038,990.00 | -26.28% | 7,353,446.00 | 1996-06-12 | 52062 | 44120 | 1 | adar1 | -6.96% | Decreased |
| 159 | RNXT | 2025-06-30 | RenovoRx, Inc. | 0.77 | 28,214,130.00 | -42.81% | 35,057,106.00 | 2021-08-26 | 26154 | 19889 | 1 | adar1 | -95.86% | Decreased |
| 160 | PRQR | 2025-06-30 | ProQR Therapeutics N.V. | 1.14 | 119,942,816.00 | -48.88% | 64,438,464.00 | 2014-09-18 | 20400 | 10000 | 1 | adar1 | -50.97% | Decreased |
| 161 | LPTX | 2025-06-30 | Leap Therapeutics, Inc. | 0.36 | 14,993,012.00 | -85.23% | 31,782,794.00 | 2017-01-25 | 11854 | 39925 | 1 | adar1 | -92.26% | Decreased |
------------------------------------------------------------ ------------------------------------------------------------ Decreased Positions (when all funds shares were added together) Sorted by Decrease in Share %
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | PFE | 2025-06-30 | Pfizer, Inc. | 22.14 | 125,565,902,848.00 | -16.89% | 5,657,705,935.00 | 1972-06-01 | 2240733 | 92439 | 2 | adar1-tang | -97.66% |
| 1 | RNXT | 2025-06-30 | RenovoRx, Inc. | 0.77 | 28,214,130.00 | -42.81% | 35,057,106.00 | 2021-08-26 | 26154 | 19889 | 1 | adar1 | -95.86% |
| 2 | PHAT | 2025-06-30 | Phathom Pharmaceuticals, Inc. | 4.03 | 280,637,120.00 | -40.65% | 56,653,838.00 | 2019-10-25 | 608236 | 63424 | 1 | adar1 | -94.90% |
| 3 | TNYA | 2025-06-30 | Tenaya Therapeutics, Inc. | 0.49 | 80,137,168.00 | -67.14% | 55,205,093.00 | 2021-07-30 | 221235 | 361969 | 1 | casdin | -94.62% |
| 4 | LPTX | 2025-06-30 | Leap Therapeutics, Inc. | 0.36 | 14,993,012.00 | -85.23% | 31,782,794.00 | 2017-01-25 | 11854 | 39925 | 1 | adar1 | -92.26% |
| 5 | IOVA | 2025-06-30 | Iovance Biotherapeutics, Inc. | 3.06 | 1,003,303,552.00 | -47.96% | 251,861,761.00 | 2010-10-15 | 3096000 | 1800000 | 1 | tang | -87.61% |
| 6 | DAWN | 2025-06-30 | Day One Biopharmaceuticals, Inc | 7.12 | 721,647,616.00 | -38.41% | 71,972,855.00 | 2021-05-27 | 5785592 | 890091 | 2 | adar1-ecor1 | -86.61% |
| 7 | PHGE | 2025-06-30 | BiomX Inc. | 0.54 | 13,474,203.00 | -29.36% | 17,770,088.00 | 2019-03-13 | 134819 | 299598 | 1 | adar1 | -85.65% |
| 8 | CADL | 2025-06-30 | Candel Therapeutics, Inc. | 4.97 | 234,760,432.00 | -36.04% | 35,925,874.00 | 2021-07-27 | 1796867 | 355112 | 1 | baker | -85.43% |
| 9 | TEVA | 2025-06-30 | Teva Pharmaceutical Industries | 13.65 | 15,656,003,584.00 | -37.44% | 1,128,838,460.00 | 1982-02-16 | 5796915 | 345878 | 1 | adar1 | -84.45% |
| 10 | ALEC | 2025-06-30 | Alector, Inc. | 0.92 | 91,168,936.00 | -46.82% | 73,332,475.00 | 2019-02-07 | 2412936 | 1723526 | 1 | adar1 | -82.89% |
| 11 | SPRO | 2025-06-30 | Spero Therapeutics, Inc. | 0.75 | 42,160,232.00 | -15.83% | 41,896,412.00 | 2017-11-02 | 417359 | 143917 | 1 | adar1 | -82.04% |
| 12 | DNA | 2025-06-30 | Ginkgo Bioworks Holdings, Inc. | 8.12 | 471,232,832.00 | -8.35% | 36,712,127.00 | 2021-04-19 | 6035546 | 536493 | 2 | casdin-opaleye | -80.08% |
| 13 | DCTH | 2025-06-30 | Delcath Systems, Inc. | 10.66 | 356,391,520.00 | -16.65% | 31,032,851.00 | 2018-05-03 | 2031636 | 149385 | 1 | adar1 | -75.58% |
| 14 | TXG | 2025-06-30 | 10x Genomics, Inc. | 8.30 | 1,023,240,640.00 | -44.11% | 106,469,868.00 | 2019-09-12 | 5504472 | 475343 | 1 | racapital | -75.55% |
| 15 | ACRS | 2025-06-30 | Aclaris Therapeutics, Inc. | 1.14 | 123,288,720.00 | -56.15% | 66,068,981.00 | 2015-10-06 | 2627000 | 1850000 | 1 | logos | -73.15% |
| 16 | PRTA | 2025-06-30 | Prothena Corporation plc | 9.20 | 495,208,384.00 | -34.80% | 32,018,442.00 | 2012-12-18 | 20486305 | 3375009 | 1 | adar1 | -70.87% |
| 17 | ZURA | 2025-06-30 | Zura Bio Limited | 1.21 | 82,733,752.00 | -39.20% | 46,618,074.00 | 2023-03-21 | 2861364 | 2725109 | 2 | adar1-deeptrack | -70.71% |
| 18 | LXEO | 2025-06-30 | Lexeo Therapeutics, Inc. | 1.98 | 65,730,060.00 | -68.77% | 21,795,488.00 | 2023-11-03 | 1145475 | 284944 | 2 | adar1-perceptive | -66.74% |
| 19 | TMO | 2025-06-30 | Thermo Fisher Scientific Inc | 438.15 | 165,398,118,400.00 | -21.13% | 376,446,298.00 | 1980-03-17 | 18853890 | 46500 | 1 | orbimed | -63.95% |
------------------------------------------------------------ ------------------------------------------------------------ Decreased Positions (when all funds shares were added together) with the Highest Fund Number
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | PCT_CHANGE | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | EWTX | 2025-06-30 | Edgewise Therapeutics, Inc. | 11.42 | 1,200,710,272.00 | -54.92% | 54,187,991.00 | 2021-03-26 | 558227811 | 42580306 | 8 | adar1-baker-cormorant-perceptive-racapital-orbimed-opaleye-tang | -0.63% |
| 1 | JANX | 2025-06-30 | Janux Therapeutics, Inc. | 28.80 | 1,702,226,816.00 | -36.09% | 37,290,619.00 | 2021-06-11 | 390957914 | 16924585 | 8 | adar1-cormorant-ecor1-logos-perceptive-racapital-orbimed-tang | -7.73% |
| 2 | SEPN | 2025-06-30 | Septerna, Inc. | 5.72 | 254,211,088.00 | -66.35% | 19,629,806.00 | 2024-10-25 | 156460787 | 14802345 | 8 | adar1-avoro-bvf-casdin-deeptrack-logos-perceptive-racapital | -7.78% |
| 3 | RYTM | 2025-06-30 | Rhythm Pharmaceuticals, Inc. | 61.74 | 3,903,431,424.00 | 7.34% | 46,955,630.00 | 2017-10-09 | 915183487 | 14483043 | 7 | adar1-baker-logos-perceptive-racapital-orbimed-opaleye | -5.30% |
| 4 | MBX | 2025-06-30 | MBX Biosciences, Inc. | 7.41 | 247,674,800.00 | -40.53% | 13,610,404.00 | 2024-09-13 | 98792722 | 8658433 | 6 | cormorant-deeptrack-ecor1-racapital-orbimed-opaleye | -19.40% |
| 5 | XENE | 2025-06-30 | Xenon Pharmaceuticals Inc. | 31.40 | 2,403,443,968.00 | -17.91% | 70,775,310.00 | 2014-11-05 | 266938262 | 8528379 | 6 | adar1-avoro-baker-deeptrack-perceptive-orbimed | -6.69% |
| 6 | AVTX | 2025-06-30 | Avalo Therapeutics, Inc. | 4.90 | 52,292,312.00 | -28.68% | 3,682,884.00 | 2015-10-14 | 18660215 | 3739522 | 6 | adar1-bvf-deeptrack-perceptive-racapital-orbimed | -14.24% |
| 7 | PCVX | 2025-06-30 | Vaxcyte, Inc. | 30.65 | 3,946,555,136.00 | -65.24% | 119,134,116.00 | 2020-06-12 | 498375308 | 15329908 | 6 | adar1-baker-cormorant-deeptrack-racapital-tang | -2.82% |
| 8 | CNTA | 2025-06-30 | Centessa Pharmaceuticals plc | 11.57 | 1,540,938,880.00 | -24.18% | 93,006,626.00 | 2021-05-28 | 119315155 | 9080301 | 6 | adar1-avoro-cormorant-deeptrack-perceptive-tang | -16.27% |
| 9 | SRPT | 2025-06-30 | Sarepta Therapeutics, Inc. | 53.79 | 5,219,356,672.00 | -53.94% | 92,551,132.00 | 1997-06-04 | 40706721 | 2380510 | 5 | adar1-casdin-deeptrack-opaleye-tang | -59.59% |
| 10 | CGON | 2025-06-30 | CG Oncology, Inc. | 19.28 | 1,469,461,760.00 | -32.78% | 60,853,824.00 | 2024-01-25 | 87868716 | 3379566 | 5 | adar1-cormorant-orbimed-opaleye-tang | -8.96% |
| 11 | DYN | 2025-06-30 | Dyne Therapeutics, Inc. | 7.04 | 796,371,840.00 | -53.96% | 97,275,317.00 | 2020-09-17 | 142002653 | 14916245 | 5 | adar1-logos-perceptive-racapital-orbimed | -8.74% |
| 12 | CRNX | 2025-06-30 | Crinetics Pharmaceuticals, Inc. | 30.42 | 2,830,535,168.00 | -21.52% | 91,642,575.00 | 2018-07-18 | 177456246 | 6170245 | 5 | adar1-baker-cormorant-ecor1-orbimed | -1.91% |
| 13 | MDGL | 2025-06-30 | Madrigal Pharmaceuticals, Inc. | 301.66 | 6,660,712,960.00 | -1.77% | 11,356,312.00 | 2007-02-06 | 1203621071 | 3977072 | 5 | adar1-avoro-baker-ecor1-logos | -3.46% |
| 14 | VRNA | 2025-06-30 | Verona Pharma plc | 65.46 | 8,622,652,416.00 | 21.92% | 493,924,450.00 | 2017-04-28 | 596788829 | 6309884 | 5 | adar1-baker-cormorant-ecor1-perceptive | -7.31% |
| 15 | ACLX | 2025-06-30 | Arcellx, Inc. | 59.15 | 3,249,937,664.00 | -12.19% | 32,601,579.00 | 2022-02-04 | 427716427 | 6495314 | 5 | adar1-baker-cormorant-perceptive-racapital | -7.57% |
| 16 | IMVT | 2025-06-30 | Immunovant, Inc. | 15.15 | 2,573,393,920.00 | -35.78% | 62,221,667.00 | 2019-06-21 | 286493392 | 17905837 | 5 | adar1-baker-deeptrack-logos-perceptive | -5.99% |
| 17 | OCUL | 2025-06-30 | Ocular Therapeutix, Inc. | 7.31 | 1,162,450,816.00 | -9.64% | 124,121,633.00 | 2014-07-25 | 236541818 | 25489420 | 4 | avoro-deeptrack-logos-opaleye | -6.17% |
| 18 | KURA | 2025-06-30 | Kura Oncology, Inc. | 5.90 | 476,587,840.00 | -20.16% | 59,769,977.00 | 2015-09-16 | 69750235 | 12088429 | 4 | adar1-bvf-ecor1-tang | -16.77% |
| 19 | ENGN | 2025-06-30 | enGene Holdings Inc. | 4.00 | 203,910,400.00 | -50.37% | 24,461,582.00 | 2022-02-01 | 27616440 | 7586934 | 4 | adar1-cormorant-deeptrack-orbimed | -2.69% |
------------------------------------------------------------ ------------------------------------------------------------ Unchanged Positions (when all funds shares were added together) Sorted by Value
| SYMBOL | DATE | Company | Price | Mkt. Cap | 3 Month Percentage Change | Float | First Traded | VALUE | SHARES | FUND_COUNT | FUND_LIST | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | SYK | 2025-06-30 | Stryker Corporation | 350.28 | 133,698,019,328.00 | -2.96% | 343,306,737.00 | 1980-03-17 | 142110296 | 359200 | 1 | orbimed |
| 1 | LAB | 2025-06-30 | Standard BioTools Inc. | 1.15 | 435,833,888.00 | -44.17% | 48,240,936.00 | 2011-02-10 | 91780069 | 76483391 | 2 | casdin-tang |
| 2 | AORT | 2025-06-30 | Artivion, Inc. | 23.37 | 997,648,960.00 | -20.35% | 36,399,595.00 | 1993-02-12 | 86884163 | 2793703 | 1 | perceptive |
| 3 | THC | 2025-06-30 | Tenet Healthcare Corporation | 123.79 | 11,775,028,224.00 | -4.24% | 93,879,671.00 | 1980-03-17 | 81840000 | 465000 | 1 | orbimed |
| 4 | ANIP | 2025-06-30 | ANI Pharmaceuticals, Inc. | 69.21 | 1,493,150,336.00 | 18.61% | 16,794,626.00 | 2000-05-05 | 66391875 | 1017500 | 2 | deeptrack-tang |
| 5 | AVBP | 2025-06-30 | ArriVent BioPharma, Inc. | 18.15 | 617,394,048.00 | -28.59% | 15,838,962.00 | 2024-01-26 | 65904931 | 3027328 | 1 | orbimed |
| 6 | KOD | 2025-06-30 | Kodiak Sciences Inc | 2.84 | 149,805,168.00 | -62.13% | 32,340,149.00 | 2018-10-04 | 64941128 | 17410490 | 2 | baker-tang |
| 7 | VOR | 2025-06-30 | Vor Biopharma Inc. | 0.70 | 87,396,400.00 | -48.91% | 38,992,387.00 | 2021-02-05 | 64226583 | 39646039 | 1 | racapital |
| 8 | OLMA | 2025-06-30 | Olema Pharmaceuticals, Inc. | 3.77 | 257,615,808.00 | -22.11% | 41,105,755.00 | 2020-11-19 | 50896781 | 11947601 | 3 | bvf-deeptrack-logos |
| 9 | ACIU | 2025-06-30 | AC Immune SA | 1.48 | 148,606,800.00 | -44.15% | 39,596,052.00 | 2016-09-23 | 40239545 | 19822436 | 1 | bvf |
| 10 | TRDA | 2025-06-30 | Entrada Therapeutics, Inc. | 7.90 | 296,997,344.00 | -40.91% | 19,019,077.00 | 2021-10-29 | 32698304 | 4865819 | 1 | baker |
| 11 | CYBN | 2025-06-30 | Cybin Inc. | 6.80 | 142,914,928.00 | -23.60% | 18,315,557.00 | 2019-09-13 | 28191105 | 3360084 | 2 | deeptrack-tang |
| 12 | CRBP | 2025-06-30 | Corbus Pharmaceuticals Holdings | 6.03 | 73,760,168.00 | -49.46% | 7,526,368.00 | 2014-10-27 | 25356168 | 3674807 | 3 | cormorant-orbimed-tang |
| 13 | SCPH | 2025-06-30 | scPharmaceuticals Inc. | 2.57 | 129,229,616.00 | -20.68% | 26,894,357.00 | 2017-11-17 | 24991802 | 6559528 | 2 | perceptive-orbimed |
| 14 | FHTX | 2025-06-30 | Foghorn Therapeutics Inc. | 3.45 | 191,862,096.00 | -21.05% | 25,845,788.00 | 2020-10-23 | 24919400 | 5302000 | 1 | bvf |
| 15 | TGTX | 2025-06-30 | TG Therapeutics, Inc. | 38.32 | 6,018,960,896.00 | 28.33% | 134,539,735.00 | 2010-05-03 | 22853650 | 635000 | 2 | opaleye-tang |
| 16 | RPTX | 2025-06-30 | Repare Therapeutics Inc. | 1.20 | 51,012,844.00 | -3.23% | 22,476,262.00 | 2020-06-19 | 18981962 | 13656088 | 2 | bvf-orbimed |
| 17 | AVDL | 2025-06-30 | Avadel Pharmaceuticals plc | 8.03 | 775,934,080.00 | 1.65% | 84,810,689.00 | 1996-06-07 | 18562875 | 2097500 | 1 | tang |
| 18 | PRLD | 2025-06-30 | Prelude Therapeutics Incorporat | 0.71 | 39,060,488.00 | -31.24% | 16,835,400.00 | 2020-09-25 | 17024175 | 21033080 | 2 | baker-orbimed |
| 19 | ACET | 2025-06-30 | Adicet Bio, Inc. | 0.54 | 44,402,276.00 | -38.63% | 61,366,056.00 | 2018-01-26 | 16599168 | 27211752 | 3 | racapital-orbimed-tang |
| 20 | OM | 2025-06-30 | Outset Medical, Inc. | 10.16 | 179,827,936.00 | -16.17% | 2,773,914.00 | 2020-09-15 | 16008326 | 833333 | 1 | perceptive |
| 21 | GSK | 2025-06-30 | GSK plc | 34.64 | 70,245,416,960.00 | 5.93% | 3,947,946,444.00 | 1980-03-28 | 15360000 | 400000 | 1 | tang |
| 22 | DBVT | 2025-06-30 | DBV Technologies S.A. | 7.98 | 218,144,480.00 | 76.55% | 28,773,868.00 | 2014-10-22 | 13386507 | 1461425 | 1 | baker |
| 23 | OBIO | 2025-06-30 | Orchestra BioMed Holdings, Inc. | 2.98 | 114,171,248.00 | -41.91% | 18,386,175.00 | 2020-08-04 | 12308050 | 4592556 | 1 | perceptive |
| 24 | ELAN | 2025-06-30 | Elanco Animal Health Incorporat | 8.44 | 4,190,105,088.00 | -29.90% | 490,780,682.00 | 2018-09-20 | 11425428 | 800100 | 1 | tang |
| 25 | VNDA | 2025-06-30 | Vanda Pharmaceuticals Inc. | 4.25 | 251,342,032.00 | -4.49% | 51,637,107.00 | 2006-04-12 | 11107609 | 2353307 | 1 | tang |
| 26 | CCCC | 2025-06-30 | C4 Therapeutics, Inc. | 1.24 | 88,027,224.00 | -64.57% | 47,230,841.00 | 2020-10-02 | 11054329 | 7730300 | 2 | orbimed-tang |
| 27 | ALT | 2025-06-30 | Altimmune, Inc. | 4.55 | 350,412,320.00 | -33.38% | 76,335,168.00 | 2017-05-26 | 10642500 | 2750000 | 1 | tang |
| 28 | RCUS | 2025-06-30 | Arcus Biosciences, Inc. | 7.88 | 834,027,072.00 | -44.27% | 65,841,832.00 | 2018-03-15 | 9250003 | 1136364 | 1 | racapital |
| 29 | NAUT | 2025-06-30 | Nautilus Biotechnology, Inc. | 0.79 | 99,783,072.00 | -57.01% | 46,630,782.00 | 2020-08-07 | 9130802 | 12594211 | 1 | perceptive |
| 30 | HRMY | 2025-06-30 | Harmony Biosciences Holdings, I | 29.17 | 1,673,970,048.00 | -19.97% | 44,329,878.00 | 2020-08-19 | 8885920 | 281200 | 1 | tang |
| 31 | NUVB | 2025-06-30 | Nuvation Bio Inc. | 1.99 | 675,941,312.00 | -25.47% | 228,079,888.00 | 2020-08-26 | 7605000 | 3900000 | 1 | tang |
| 32 | VCYT | 2025-06-30 | Veracyte, Inc. | 31.80 | 2,478,644,480.00 | -25.67% | 77,565,181.00 | 2013-10-30 | 7468605 | 276308 | 1 | casdin |
| 33 | SGMT | 2025-06-30 | Sagimet Biosciences Inc. – Seri | 2.31 | 74,371,144.00 | -49.51% | 19,428,281.00 | 2023-07-17 | 7261830 | 952996 | 1 | baker |
| 34 | BLCO | 2025-06-30 | Bausch + Lomb Corporation | 11.40 | 4,027,311,872.00 | -34.37% | 41,284,904.00 | 2022-05-06 | 7155500 | 550000 | 1 | tang |
| 35 | PMVP | 2025-06-30 | PMV Pharmaceuticals, Inc. | 0.87 | 45,286,100.00 | -37.27% | 34,407,051.00 | 2020-09-25 | 6970876 | 6576299 | 2 | adar1-orbimed |
| 36 | ADAP | 2025-06-30 | Adaptimmune Therapeutics plc | 0.24 | 61,272,660.00 | -58.21% | 1,054,028,457.00 | 2015-05-06 | 6568756 | 27404070 | 1 | ecor1 |
| 37 | BMEA | 2025-06-30 | Biomea Fusion, Inc. | 1.75 | 65,751,524.00 | -57.83% | 29,397,656.00 | 2021-04-16 | 6427570 | 3570872 | 1 | cormorant |
| 38 | IBRX | 2025-06-30 | ImmunityBio, Inc. | 2.63 | 2,320,888,320.00 | 6.05% | 204,851,716.00 | 2015-07-28 | 6159999 | 2333333 | 1 | tang |
| 39 | SKYE | 2025-06-30 | Skye Bioscience, Inc. | 1.41 | 43,674,184.00 | -49.64% | 15,691,401.00 | 2015-01-06 | 6063667 | 1450638 | 1 | baker |
| 40 | SANA | 2025-06-30 | Sana Biotechnology, Inc. | 1.76 | 396,043,968.00 | -49.13% | 134,123,841.00 | 2021-02-04 | 5544491 | 2030949 | 1 | baker |
| 41 | MOLN | 2025-06-30 | Molecular Partners AG | 3.87 | 145,289,056.00 | -28.32% | 14,882,000.00 | 2021-06-16 | 5185697 | 1353968 | 1 | bvf |
| 42 | BDTX | 2025-06-30 | Black Diamond Therapeutics, Inc | 1.44 | 81,593,568.00 | -35.71% | 38,983,042.00 | 2020-01-31 | 5134118 | 2070209 | 1 | tang |
| 43 | CNTX | 2025-06-30 | Context Therapeutics Inc. | 0.78 | 69,978,248.00 | -24.26% | 40,555,266.00 | 2021-10-20 | 5091198 | 7770449 | 2 | adar1-deeptrack |
| 44 | KZR | 2025-06-30 | Kezar Life Sciences, Inc. | 4.16 | 30,392,126.00 | -34.28% | 4,911,032.00 | 2018-06-21 | 4855276 | 1060104 | 3 | adar1-orbimed-tang |
| 45 | NSPR | 2025-06-30 | InspireMD Inc. | 2.56 | 76,006,144.00 | -3.40% | 16,807,131.00 | 2011-04-12 | 4842829 | 2133405 | 1 | orbimed |
| 46 | GMAB | 2025-06-30 | Genmab A/S | 20.04 | 12,541,773,824.00 | -8.07% | 62,846,320.00 | 2009-06-01 | 4132000 | 200000 | 1 | tang |
| 47 | LNTH | 2025-06-30 | Lantheus Holdings, Inc. | 101.32 | 6,951,696,384.00 | 7.73% | 61,829,554.00 | 2015-06-25 | 4093000 | 50000 | 1 | tang |
| 48 | ATYR | 2025-06-30 | aTyr Pharma, Inc. | 2.97 | 263,910,048.00 | -9.73% | 81,953,409.00 | 2015-05-07 | 3402649 | 671134 | 1 | tang |
| 49 | QTTB | 2025-06-30 | Q32 Bio Inc. | 2.08 | 25,371,008.00 | -32.90% | 5,426,353.00 | 2018-03-28 | 3356951 | 2252987 | 1 | orbimed |
| 50 | ABSI | 2025-06-30 | Absci Corporation | 3.02 | 384,606,048.00 | 5.96% | 100,727,471.00 | 2021-07-22 | 2501278 | 973260 | 1 | casdin |
| 51 | IVA | 2025-06-30 | Inventiva S.A. – American Depos | 3.36 | 320,705,504.00 | 54.69% | 24,956,237.00 | 2020-07-10 | 2140445 | 686040 | 1 | bvf |
| 52 | CDNA | 2025-06-30 | CareDx, Inc. | 18.81 | 1,042,561,152.00 | -24.97% | 54,071,844.00 | 2014-07-17 | 1954000 | 100000 | 1 | tang |
| 53 | ATHA | 2025-06-30 | Athira Pharma, Inc. | 0.25 | 9,760,600.00 | -52.92% | 27,560,062.00 | 2020-09-18 | 1812895 | 6002964 | 2 | perceptive-tang |
| 54 | SABS | 2025-06-30 | SAB Biotherapeutics, Inc. | 1.23 | 11,352,002.00 | -66.39% | 6,791,463.00 | 2021-02-09 | 1606196 | 917826 | 1 | bvf |
| 55 | VTVT | 2025-06-30 | vTv Therapeutics Inc. | 22.23 | 58,775,676.00 | 57.66% | 1,072,776.00 | 2015-07-30 | 1459710 | 97314 | 1 | baker |
| 56 | OPRX | 2025-06-30 | OptimizeRx Corporation | 8.13 | 150,326,960.00 | 67.63% | 14,276,611.00 | 2007-11-28 | 1350000 | 100000 | 1 | tang |
| 57 | ALXO | 2025-06-30 | ALX Oncology Holdings Inc. | 0.55 | 29,361,256.00 | -66.67% | 32,339,047.00 | 2020-07-17 | 1310996 | 3158265 | 1 | tang |
| 58 | OVID | 2025-06-30 | Ovid Therapeutics Inc. | 0.29 | 20,512,244.00 | -58.65% | 50,468,940.00 | 2017-05-05 | 1309600 | 3969685 | 2 | adar1-bvf |
| 59 | ENTA | 2025-06-30 | Enanta Pharmaceuticals, Inc. | 5.10 | 108,795,744.00 | -0.39% | 14,292,378.00 | 2013-03-21 | 957512 | 126655 | 1 | tang |
| 60 | PACB | 2025-06-30 | Pacific Biosciences of Californ | 1.17 | 348,486,816.00 | -31.18% | 295,618,336.00 | 2010-10-27 | 897471 | 723767 | 1 | casdin |
| 61 | SGRY | 2025-06-30 | Surgery Partners, Inc. | 20.99 | 2,678,596,864.00 | -0.80% | 74,906,623.00 | 2015-09-30 | 889200 | 40000 | 1 | adar1 |
| 62 | VTGN | 2025-06-30 | VistaGen Therapeutics, Inc. | 2.22 | 67,537,288.00 | -22.92% | 20,224,817.00 | 2011-06-21 | 841530 | 420765 | 1 | adar1 |
| 63 | PBYI | 2025-06-30 | Puma Biotechnology Inc | 2.86 | 141,886,880.00 | -4.03% | 42,095,259.00 | 2012-04-24 | 686000 | 200000 | 1 | tang |
| 64 | ANRO | 2025-06-30 | Alto Neuroscience, Inc. | 2.13 | 57,663,576.00 | -49.88% | 19,503,574.00 | 2024-02-02 | 550000 | 250000 | 1 | orbimed |
| 65 | FTRE | 2025-06-30 | Fortrea Holdings Inc. | 5.18 | 467,236,000.00 | -71.71% | 78,282,776.00 | 2023-06-20 | 494000 | 100000 | 1 | tang |
| 66 | DHAI | 2025-06-30 | DIH Holding US, Inc. | 0.14 | 6,433,003.00 | -90.08% | 17,851,910.00 | 2024-02-14 | 468984 | 1915000 | 1 | orbimed |
| 67 | NLSP | 2025-06-30 | NLS Pharmaceutics Ltd. | 1.35 | 5,476,437.00 | -34.78% | 457,622.00 | 2021-01-29 | 416660 | 143676 | 1 | bvf |
| 68 | XERS | 2025-06-30 | Xeris Biopharma Holdings, Inc. | 4.16 | 640,390,400.00 | 26.83% | 146,657,227.00 | 2018-06-21 | 375561 | 80420 | 1 | orbimed |
| 69 | APYX | 2025-06-30 | Apyx Medical Corporation | 0.96 | 36,206,556.00 | -35.70% | 29,121,701.00 | 2019-01-02 | 337500 | 150000 | 1 | perceptive |
| 70 | BMRN | 2025-06-30 | BioMarin Pharmaceutical Inc. | 59.17 | 11,346,083,840.00 | -5.37% | 178,517,719.00 | 1999-07-26 | 269353 | 4900 | 1 | adar1 |
| 71 | ENSC | 2025-06-30 | Ensysce Biosciences, Inc. | 2.03 | 2,852,413.00 | -71.69% | 896,490.00 | 2018-03-14 | 193265 | 86666 | 1 | perceptive |
| 72 | AVXL | 2025-06-30 | Anavex Life Sciences Corp. | 8.95 | 761,324,544.00 | -9.14% | 82,257,080.00 | 2006-08-02 | 149558 | 16221 | 1 | adar1 |
| 73 | SLN | 2025-06-30 | Silence Therapeutics Plc – Amer | 2.57 | 121,367,472.00 | -56.44% | 66,438,057.00 | 2020-09-08 | 108129 | 18643 | 1 | adar1 |
| 74 | ACHV | 2025-06-30 | Achieve Life Sciences, Inc. | 1.99 | 69,023,352.00 | -30.18% | 29,417,797.00 | 1995-10-12 | 97571 | 43173 | 1 | adar1 |
| 75 | OGN | 2025-06-30 | Organon & Co. | 11.18 | 2,883,880,960.00 | -28.61% | 256,822,907.00 | 2021-05-14 | 96800 | 10000 | 1 | adar1 |
| 76 | MOVE | 2025-06-30 | Movano Inc. | 0.81 | 5,373,143.00 | -86.01% | 5,425,772.00 | 2021-03-23 | 13019 | 19146 | 1 | adar1 |
| 77 | CNTB | 2025-06-30 | Connect Biopharma Holdings Limi | 0.62 | 34,593,248.00 | -42.45% | 14,322,715.00 | 2021-03-19 | 10094 | 10300 | 1 | adar1 |
| 78 | OPT | 2025-06-30 | Opthea Limited | 3.41 | 524,819,488.00 | -4.62% | 785,981,303.00 | 2020-10-16 | 0 | 2087320 | 1 | baker |
------------------------------------------------------------ ------------------------------------------------------------ 13F positions: New: ACTU,BHC,BOLT,CABA,CAI,CBIO,CPRX,CRL,CRMD,FENC,GALT,GMED,HNGE,IFRX,LUNG,LYEL,LYRA,MCRB,MRK,MTD,MURA,NERV,NKTR,NVNO,OMDA,PCRX,PEN,RAPT,RLMD,TPST,TRIB,UNCY Increased: ABOS,ABUS,ABVX,ACAD,AGIO,AKRO,ALKS,ALMS,ANIK,APLS,ARDX,ARVN,ARWR,ASND,AUPH,AVIR,AXSM,BCAB,BHVN,BIIB,BNTX,BSX,CDTX,CDXS,CELC,CHRS,CLDX,CLOV,CRVS,CTMX,CYTK,DERM,DNTH,DSGN,ELDN,ELVN,EPIX,ERAS,ESTA,ETON,EW,FBRX,FDMT,GHRS,GPCR,HLVX,HOWL,IBIO,IDXX,IGMS,ILMN,IMCR,INCY,INSM,IRON,ISRG,ITOS,JAZZ,KNSA,KROS,KRYS,KYMR,LEGN,LENZ,LLY,LQDA,LRMR,MGNX,MGTX,MGX,MLTX,MLYS,MNMD,MNPR,MRUS,NTLA,NTRA,OABI,PHVS,PRAX,PTCT,PTGX,PYPD,PYXS,QURE,RAPP,RARE,REGN,REPL,RGEN,RLAY,RNA,ROIV,RVMD,RXRX,RZLT,SAVA,SEER,SMMT,SNDX,SNWV,STOK,STTK,SVRA,SYRE,TBPH,TECX,TENX,TERN,TNGX,TRML,TRVI,TSHA,TVTX,TYRA,UNH,VERA,VRDN,VRTX,VYGR,VYNE,WGS,WVE,XNCR,ZNTL,ZYME Closed: ADPT,AMGN,BOLD,CAPR,CBLL,CRDF,DXCM,GEHC,GILD,GKOS,HUMA,KMTS,LXRX,MREO,NBTX,OTLK,RLYB,RVPH,SGMO,TIL,XLO,XTNT Decreased: ABCL,ACHC,ACLX,ACRS,ACRV,ADCT,ADMA,ALDX,ALEC,ALGS,ALNY,AMLX,ANAB,ANNX,APGE,APLT,AQST,ARGX,ARQT,ATRA,ATXS,AUTL,AVR,AVTX,AZN,BBIO,BCAX,BCRX,BCYC,BDSX,BEAM,BIOA,BLFS,CADL,CASI,CERS,CGEM,CGON,CMMB,CMPS,CMPX,CNTA,CRGX,CRNX,CRSP,CTNM,DAWN,DCTH,DNA,DNLI,DRUG,DTIL,DVAX,DYN,ENGN,EOLS,ETNB,EWTX,EXAS,EYPT,FATE,FOLD,FULC,GERN,GH,GLPG,GLUE,GOSS,GRAL,HROW,HRTX,IDYA,IKT,IMNM,IMTX,IMUX,IMVT,INBX,INO,IONS,IOVA,IPSC,ITGR,IVVD,JANX,JNJ,KALA,KALV,KPRX,KRRO,KURA,LPTX,LSB,LXEO,MBX,MDGL,MIRM,MNKD,MRNA,NAMS,NBIX,NGNE,NKTX,NMRA,NPCE,NRIX,NUVL,NVAX,OCUL,ORIC,PCVX,PEPG,PFE,PHAT,PHGE,PLRX,PODD,PRME,PRQR,PRTA,QNCX,RCEL,RCKT,RGNX,RNXT,RXST,RYTM,SEPN,SERA,SIBN,SLDB,SLNO,SNY,SPRO,SPRY,SRPT,SRRK,SRZN,STRO,TARA,TARS,TCRX,TDOC,TEVA,TMO,TNYA,TRAW,TXG,TXMD,UPB,URGN,UTHR,VIR,VKTX,VRNA,VSTM,VTRS,VTYX,XENE,XOMA,ZLAB,ZURA Unchanged: ABSI,ACET,ACHV,ACIU,ADAP,ALT,ALXO,ANIP,ANRO,AORT,APYX,ATHA,ATYR,AVBP,AVDL,AVXL,BDTX,BLCO,BMEA,BMRN,CCCC,CDNA,CNTB,CNTX,CRBP,CYBN,DBVT,DHAI,ELAN,ENSC,ENTA,FHTX,FTRE,GMAB,GSK,HRMY,IBRX,IVA,KOD,KZR,LAB,LNTH,MOLN,MOVE,NAUT,NLSP,NSPR,NUVB,OBIO,OGN,OLMA,OM,OPRX,OPT,OVID,PACB,PBYI,PMVP,PRLD,QTTB,RCUS,RPTX,SABS,SANA,SCPH,SGMT,SGRY,SKYE,SLN,SYK,TGTX,THC,TRDA,VCYT,VNDA,VOR,VTGN,VTVT,XERS
End of Report - 2025-08-14 17:08:07